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ABSTRACT 
 
This research was carried out to study the efficacy of three 
synthetic anti-malarial drugs (primaquine at level 31.2, 125 and 250 ppm, 
fancedar (86.625mg) and artesunate (33mg) and one anticoccidial 
medication (amprolium 60g/100 Liter) as a reference. The drugs were 
administered in drinking water to treat Eimeria tenella in chickens. 
Atotal of 280 3- week old male Hisex strain chicks were divided in 
to 14 even groups , control naive (uninfected unmedicated group), 
(infected unmedicated group) ,6 groups of infected treated by anti-
malarial medications (primaquine 31.2, 125 and 250 ppm, fancedar 
86.625mg and artesunate 33mg) and anti-coccidial drug (amprolium 
60g/100 Liter) and 6 groups of control uninfected medicated, as 
prophylactic additives and to test their impact on the chicks behaviour 
and to test the toxicity. Infection was carried out by inoculation of 
sporulated oocyst 1×104 in the chicks' crops. Treatment started on the 
third day of infection. 
Results indiceted that utilization of primaquine level 125 ppm 
demonstrated heavier weight gain. All the sick chicks recovered from  
the disease and none of them  died and no oocysts were recovered in the 
faeces. During treatment of birds with primaquine level 31.2 ppm, feed 
intake was lower among birds. All the sick chicks recovered from the 
disease and none of them died and no oocysts were recovered in the 
faeces.  During treatment of chicks with primaquine level 250 ppm, 
secured the lowest food intake with the highest mortality rate. Among 
this group the lowest value of mean cell value (MCV) and toxic 
 
 
ix
symptoms were recorded. The administration of artesunate  revealed a 
higher food intake. All the sick chicks recovered from the disease and 
none of them died rate and no oocysts were recovered in the faeces and 
the highest values of MCV were recorded. Administration of fancedar 
recorded a higher food intake with all the sick chicks recovered from  the 
disease and non of them died, and no oocysts were recovered in the 
faeces with administration of anticoccidial (amprolium), all of  the sick 
chicks recovered from the disease and non of them died, and exerted the 
highest values of MCV.  
It is concluded that antimalarial drugs (primaquine 31.2, 125 and 
250 ppm artesunate 33 mg, fancedar 86.625 mg) for treatment of Eimeria 
tenella was effective compared with anticoccidial drug (amprolium). 
However, the high level of pimaquine 250 ppm as prophylactic additive 
was toxic.   
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 اﻟﻤﺴﺘﺨﻠﺺ
 ﺒﺭﺍﻴﻤﻭﻜﻭﻴﻥ) ﺎﺭﻴﺜﻼﺜﺔ ﺃﻨﻭﻉ ﻤﻥ ﺃﺩﻭﻴﺔ ﺍﻟﻤﻼﺃﺠﺭﻱ ﻫﺫﺍ ﺍﻟﺒﺤﺙ ﻟﺩﺭﺍﺴﺔ ﻜﻔﺎﺀﺓ 
 (ﻤل ﺠﺭﺍﻡ 526.68)، ﻓﺎﻨﺴﺩﺍﺭ ﺠﺯﺀ ﻤﻥ ﺍﻟﻤﻠﻴﻭﻥ052 ﻭ521، 2.13ﺒﻤﺴﺘﻭﻴﺎﺕ 
ﻤﻊ ﺍﺴﺘﺨﺩﻡ ﺩﻭﺍﺀ ﻟﻌﻼﺝ ﺍﻻﻴﻤﻴﺭﻴﺎ ﺘﻨﻴﻼ ﻓﻲ ﺍﻟﺩﻭﺍﺠﻥ (  ﻤل ﺠﺭﺍﻡ33 )ﻭﺍﺭﺘﻴﺜﻨﻴﺕ
 ﺘﻡ ﺇﻋﻁﺎﺀ ﺍﻷﺩﻭﻴﺔ ﻓﻲ .ﻤﺭﺠﻊﻜ( ﻟﺘﺭ001/ ﺠﺭﺍﻡ06ﺍﻤﺒﺭﻭﻟﻴﻭﻡ)ﻤﻀﺎﺩ ﻟﻠﻜﻭﻜﺴﻴﺩﻴﺎ 
  .ﻤﺎﺀ ﺍﻟﺸﺭﺏ
 ﺍﻟﻬﺎﻴﺴﻜﺱ  ﻤﻥ ﺴﻼﻟﺔ ﺍﺴﺎﺒﻴﻊ3ﻋﻤﺭ ﺫﻜﻭﺭ ﻜﺘﻜﻭﺕ 082ﺃﺠﺭﻴﺕ ﻫﺫﻩ ﺍﻟﺩﺍﺭﺴﺔ ﻋﻠﻲ 
ﻤﺠﻤﻭﻋﺔ : ﻋﻠﻲ ﺍﻟﻨﺤﻭ ﺍﻟﺘﺎﻟﻲ ﺒﺎﻟﺘﺴﺎﻭﻯ ﻤﺠﻤﻭﻋﺔ41ﺇﻟﻲ  ﻭﺯﻋﺕ ﻫﺫﻩ ﺍﻟﻁﻴﻭﺭ ،
ﻭﻤﺠﻤﻭﻋﺔ ﻤﺼﺎﺒﺔ ﺒﺎﻟﻌﺩﻭﻱ ﻭﻟﻴﺴﺕ  ﻟﺠﺔﻏﻴﺭ ﺍﻟﻤﺼﺎﺒﺔ ﺒﺎﻟﻌﺩﻭﻱ ﻭﻟﻴﺴﺕ ﻤﻌﺎﺍﻟﺘﺤﻜﻡ 
 ﺃﺩﻭﻴﺔ ﺍﻟﻤﻼﺭﻴﺎ ﺘﻡ ﺍﻋﻁﺎﺌﻬﺎﺤﻜﻡ ﻤﺼﺎﺒﺔ ﺒﺎﻟﻌﺩﻭﻱ ﻭ ﻤﺠﻤﻭﻋﺎﺕ ﺘ6ﻭﻤﻌﺎﻟﺠﺔ 
 ل ﺠﺭﺍﻡ ﻤ526.68، ﻓﺎﻨﺴﺩﺍﺭﻥ ﺍﻟﻤﻠﻴﻭﻥ ﺠﺯﺀ ﻤ052 ﻭ521، 2.13ﺒﺭﻴﻤﺎﻜﻭﻴﻥ )
. (ﺘﺭ ﻟ001/ ﺠﺭﺍﻡ06 ﺃﻤﺒﺭﻭﻟﻴﻭﻡ )ﺍﻟﻜﻭﻜﺴﻴﺩﻴﺎﺃﺩﻭﻴﺔ ﻭ ( ﻤل ﺠﺭﺍﻡ33 ﻭﺍﺭﺘﻴﺜﻨﻴﺕ
ﻟﻤﻼﺭﻴﺎ ﻤﺼﺎﺒﺔ ﺒﺎﻟﻌﺩﻭﻱ ﻭﻤﻌﺎﻟﺠﺔ ﺒﺄﺩﻭﻴﺔ ﺍﻏﻴﺭ  ﻤﺠﻤﻭﻋﺎﺕ 6ﺇﻀﺎﻓﺔ ﺇﻟﻲ 
 ﺩﺠﺎﺝﺍﻟﻋﻠﻰ ﺴﻠﻭﻙ  ﻹﺨﺘﺒﺎﺭ ﺍﻟﺴﻤﻴﺔ ﻭﺃﺜﺭ ﻫﺫﻩ ﺍﻷﺩﻭﻴﺔ ﻭﺫﻟﻙ ﻭﺍﻟﻜﻭﻜﺴﻴﺩﻴﺎ
ﻭﺫﻟﻙ  ﺍﻟﻤﺘﺒﻭﻏﺔﻜﻴﺎﺱ ﺍﻟﺒﻴﻀﻴﺔ ﺍﻻ ﻤﻥ 014 × 1ﺍﻟﻌﺩﻭﻱ ﺘﻤﺕ ﻭ .ﻭﻜﻤﻀﺎﻓﺎﺕ ﻭﻗﺎﺌﻴﺔ
ﻴﻭﻡ ﺍﻟﺜﺎﻟﺙ ﻤﻥ ﺒﺩﺀ  ﻤﻥ ﺍﻟ ﺇﻋﻁﺎﺀ ﺍﻷﺩﻭﻴﺔ ﻭﺒﺩﺃﺩﺠﺎﺝ ﺒﺩﺍﺨل ﺤﻭﺼﻼﺕ ﺍﻟﺎﻟﺘﺠﺭﻴﻊﺒ
ﺒﻘﺎﺀ  ﺍﻥ ﺃﺜﻘل ﻭﺯﻥ، ﻭ ﺍﻨﻪﻟﻤﻠﻴﻭﻥ ﺃﻭﻀﺢ ﺠﺯﺀ ﻤﻥ ﺍ521 ﺒﺭﻴﻤﺎﻜﻭﻴﻥ ﺍﻋﻁﺎﺀ ،ﺍﻟﻌﺩﻭﻱ
 ﻓﻲ ﺘﺴﺠلﺍﻻﻜﻴﺎﺱ ﺍﻟﺒﻴﻀﻴﺔ ﺍﻟﻤﺘﺒﻭﻏﺔ ﻟﻡ  ﻭ ﺍﻟﻤﺼﺎﺏ ﻟﻡ ﻴﺴﺠل ﺍﻟﺤﻰﺍﻟﺩﺠﺎﺝ
 ﺃﻅﻬﺭ ﺃﻗل ﺇﺴﺘﻬﻼﻙ ﺠﺯﺀ ﻤﻥ ﺍﻟﻤﻠﻴﻭﻥ 2.13 ﺒﺭﻴﻤﺎﻜﻭﻴﻥ ﺍﻋﻁﺎﺀﺒﻴﻨﻤﺎ . ﺍﻟﺸﺭﻴﺤﺔ
ﺔ ﻟﻡ ﺘﺭﻱ ﻏﻭ ﺍﻻﻜﻴﺎﺱ ﺍﻟﺒﻴﻀﻴﺔ ﺍﻟﻤﺘﺒﻭ ﻭﺒﻘﺎﺀ ﺍﻟﺩﺠﺎﺝ ﺍﻟﺤﻰ ﺍﻟﻤﺼﺎﺏ ﻟﻡ ﻴﺴﺠل ﻏﺫﺍﺀ
ﻤﻠﻴﻭﻥ ﺃﻭﻀﺢ ﺃﻗل ﺇﺴﺘﻬﻼﻙ  ﺠﺯﺀ ﻤﻥ ﺍﻟ052 ﺍﻟﺒﺭﺍﻴﻤﺎﻜﻴﻥ ﺍﻋﻁﺎﺀﺒﻴﻨﻤﺎ . ﺒﺎﻟﺸﺭﻴﺤﺔ
ﺍﻟﻨﻔﻭﻕ ﻋﺎﻟﻲ ﻭﺃﻅﻬﺭ ﺃﻋﺭﺍﺽ ، ﻤﻌﺩل ﺒﻘﺎﺀ ﺍﻟﺩﺠﺎﺝ ﺍﻟﺤﻲ ﺍﻟﻤﺼﺎﺏ ﻟﻡ ﻴﺴﺠلﻏﺫﺍﺀ ﻭ 
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 ﺍﻻﺭﺘﻭﺴﻨﻴﺕ ﺴﺠل ﺃﻋﻠﻲ ﺍﻋﻁﺎﺀﺒﻴﻨﻤﺎ . ﺃﻗل ﻤﺘﻭﺴﻁ ﻤﻥ ﺘﺭﻜﻴﺯ ﺨﻼﻴﺎ ﺍﻟﺩﻡﺴﻤﻴﺔ ﻭ
ﺍﻻﻜﻴﺎﺱ ﺍﻟﺒﻴﻀﻴﺔ ﺍﻟﻤﺘﺒﻭﻏﺔ ﻭﺏ ﻟﻡ ﻴﺴﺠل ﺍﺴﺘﻬﻼﻙ ﻏﺫﺍﺀ ﻭ ﺒﻘﺎﺀ ﺍﻟﺩﺠﺎﺝ ﺍﻟﺤﻲ ﺍﻟﻤﺼﺎ
ﺇﺴﺘﺨﺩﺍﻡ . ل ﺃﻋﻠﻲ ﻤﺘﻭﺴﻁ ﻤﻥ ﺘﺭﻜﻴﺯ ﺨﻼﻴﺎ ﺍﻟﺩﻡﺴﺠﻭ ﻓﻲ ﺍﻟﺸﺭﻴﺤﺔ ﺘﺴﺠلﻟﻡ 
ﻟﻡ ﻴﺴﺠل ﺍﻟﻨﻔﻭﻕ  ﺒﻘﺎﺀ ﺍﻟﺩﺠﺎﺝ ﺍﻟﺤﻲ ﺍﻟﻤﺼﺎﺏ ﻔﺎﻨﺴﺩﺍﺭ ﺴﺠل ﺇﻋﻠﻲ ﺇﺴﺘﻬﻼﻙ ﻏﺫﺍﺀ ﻭﺍﻟ
ﺃﻤﺒﺭﻭﻟﻴﻭﻡ ﺒﻘﺎﺀ ﺍﻟﺩﺠﺎﺝ ﺍﻟﺤﻲ .  ﻓﻲ ﺍﻟﺸﺭﻴﺤﺔﺘﺴﺠلﺔ ﻟﻡ ﻏﺍﻻﻜﻴﺎﺱ ﺍﻟﺒﻴﻀﻴﺔ ﺍﻟﻤﺘﺒﻭﻭ
ﻴﺎ ﺍﻟﺩﻡ ﻭﻟﻜﻥ ﻟﻡ ﻴﺴﺠل ﺴﺠل ﺇﻋﻠﻲ ﻤﺘﻭﺴﻁ ﻤﻥ ﺘﺭﻜﻴﺯ ﺨﻼﺼﺎﺏ ﻟﻡ ﻴﺴﺠل، ﻭﺍﻟﻤ
ﺍﻥ ﺇﺴﺘﺨﺩﺍﻡ ﺃﺩﻭﻴﺔ ﺍﻟﻤﻼﺭﻴﺎ ﻓﻲ ﻤﻌﺎﻟﺠﺔ ﺍﻻﻴﻤﻴﺭﻴﺎ ﺘﻨﻴﻼ ﻜل ﻫﺫﺍ ﻴﻭﻀﺢ  ﻭ.ﻲ ﻭﺯﻥﺃﻋﻠ
( ﺍﻷﻤﺒﺭﻭﻟﻴﻡ)ﻤﻀﺎﺩﺍﺕ ﺍﻟﻜﻭﻜﺴﻴﺩﻴﺎ ﺃﻅﻬﺭ ﻓﻌﺎﻟﻴﺔ ﺩﻭﺍﺌﻴﺔ ﻤﻘﺎﺭﻨﺔ ﻤﻊ ﺃﺩﻭﻴﺔ ﻤﻀﺎﺩﺍﺕ 
 ﺠﺯﺀ ﻤﻥ ﺍﻟﻤﻠﻴﻭﻥ 052ﻋﻠﻰ ﺍﻟﺭﻏﻡ ﻤﻥ ﺍﻟﻤﺴﺘﻭﻴﺎﺕ ﺍﻟﻌﻠﻴﺎ ﻤﻥ ﺍﻟﺒﺭﺍﻴﻤﻭﻜﻭﻴﻥ 
 .ﻜﻤﻀﺎﻓﺎﺕ ﻭﻗﺎﺌﻴﺔ ﺴﺠﻠﺕ ﺍﻋﺭﺍﺽ ﺴﻤﻴﺔ
 
 
1
INTRODUCTION  
Coccidiosis is a common disease that causes great economic losses 
in poultry industry. Coccidiosis is a self-limiting, infectious disease of 
the digestive tract caused by host specific intracellular protozoal parasites 
of the genus Eimeria. Eimeria species are considered the most 
pathogenic of the parasitic protozoa of poultry (Kheissin, 1967; Beyer, 
1989).  The parasite multiplies in the intestinal tract of poultry produces 
tissue damage, resulting in reduced growth and increased susceptibility to 
pathogens (McDougald, 2003). Eimeria species the rigid host specificity; 
meaning that species which infects chickens does not infect the other host 
genus vice versa (Julie and Helm, 1999). Most species of Eimeria have 
characteristic site of invasion (tissue specificity) generally in epithelial 
cells of endodermal origin and particularly of the intestinal villi. These 
locations are so characteristic that they are often used as diagnostic 
features of the individual species (Johnson and Reid, 1970). 
Nine species of coccidia occur in poultry. Most of them are 
pathogenic to varying degrees. E. tenella is one of the most common and 
pathogenic coccidian of poultry. Caecal coccidiosis disease entity high 
morbidity and high mortality.  
Hypothetical constructive and objectives of this study was build on 
the hypothesis of test efficacy of anti-malarial drugs as a medications of 
coccidiosis infection by E. tenella in accordance with their susceptibility 
to these compounds, which have similar metabolic function to those of 
blood cell parasitizing protozoa like plasmodia and prioplasma, which 
are easily suppressed by this class of compound and have the same 
phylum. 
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CHAPTER ONE 
LITERTURE REVIEW 
1.1: Classification of Eimeria spp.: 
Coccidiosis is a self-limiting, infectious disease of the digestive 
tract caused by host specific intracellular protozoal parasites of the genus 
Eimeria. Coccidia are classified under the subkingdom Protozoa of the 
phylum Apicomplexa (Jeurissen et al., 1996). 
Domestic poultry and birds are affected by coccidia called Eimeria 
(scientific name). There are different types or species of Eimeria that 
affect poultry and each are host-specific meaning that a species that 
infects chickens does not infect turkeys and vice versa (Julie and Helm, 
1999).  
The complete sequences of the small subunit ribosomal RNA 
(SSU-rRNA) gene of isolates of seven additional Eimeria species (six 
avian and one mammalian) were submitted to Gene Bank (Barta, et al., 
1997). The usage of these sequences, in addition to those previously 
available for human associated Cyclospora and several Eimeria species 
Relman et al. (1996) reevaluate the phylogenetic relatedness of 
Cyclospora and Eimeria. Both of the previous phylogenetic analyses 
included sequences for E. tenella and E. mitis isolaes; thus, two 
sequences for each of these species we used. 
Currently classified as an Eimeria species is known to be 
pathogenic for humans. Eimeria is the largest genus of coccidian 
parasites and reportedly includes more than 1,500 named species 
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(Levine, et al., 1970). However, the current criteria cited by Sogin (1989) 
for naming new species of Eimeria. This criteria include host specificity, 
morphologic characteristics of oocysts, duration of prepatent and patent 
periods, location of the infection in the host, and pathogenicity, which are 
suboptimal, and the available data for some Eimeria species named in the 
past are incomplete. Thus, some Eimeria species may be synonymous, 
and some organisms thought to belong to the same species may not. 
Moreover, the possibility even exists that human-associated Cyclospora 
is synonymous with a previously named Eimeria species. Although no 
molecular data are available for the type species of the Cyclospora genus 
or for the Cyclospora species that are not known to be human-associated. 
Levine, et al. (1980) cited that the sub-kingdom protozoa includes 
over 65000 named species,of which over half are fossil and 
approximately 10,000 are parasitic. Among living species, this includes 
approximately 250 parasitic and 11,300 free-living sarcodines (of which 
approximately 4,600 are foraminiferids); approximately 1,8000 parasitic 
and 5,100 free-living flagellates; approximately 5,600 parasitic 
"Sporozoa" (including Apicomplexa, Microspora, Myxospora, and 
Ascetospora); and approximately 2,5000 parasitic and 4,700 free-living 
ciliates. There are undoubtedly thousands more still unnamed. Moreover, 
they were reported that seven phyla of protozoa are accepted in this 
classification--sarcomastigophora, labyrinthomorpha, apicomplexa, 
microspora, ascetospora, myxospora, and ciliophora.  
King-Hwa et al. (2007) cited that Eimeria tenella is an intracellular 
protozoan parasite that infects the intestinal tracts of domestic fowl and 
causes coccidiosis, serious and sometimes lethal enteritis. Eimeria falls in 
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the same phylum (Apicomplexa) as several human and animal parasites 
such as Cryptosporidium, Toxoplasma, and the malaria parasite, 
Plasmodium. The authors were reported the sequencing and analysis of 
the first chromosome of E. tenella, a chromosome believed to carry loci 
associated with drug resistance and known to differ between virulent and 
attenuated strains of the parasite. The researchers pointed out that the 
chromosome which appears to be representative of the genome is gene-
dense and rich in simple-sequence repeats, many of which appear to give 
rise to repetitive amino acid tracts in the predicted proteins. Moreover, 
most striking is the segmentation of the chromosome into repeat-rich 
regions peppered with transposon-like elements and telomere-like 
repeats, alternating with repeat-free regions. Moreover, predicted genes 
differ in character between the two types of segment, and the repeat-rich 
regions appear to be associated with strain-to-strain variation. 
Reclassification, on the basis of phylogenetic analysis, of human 
associated Cyclospora as an Eimeria species may stimulate productive 
research by suggesting possible animal reservoirs of human-associated 
Cyclospora (which may or may not infect other animals). In addition, 
animal models and cell culture systems that have been developed for 
Eimeria may prove useful for Cyclospora. However, it remains to be 
seen whether the biologic characteristics of Cyclospora are similar to 
those of the Eimeria species to which Cyclospora is closely related on 
the basis of phylogenetic criteria (Dispatches, 1997). 
The published classification of Eimeria is that of Levine (1973; 
1984):  Phylum: Apicomplexa. Class: Sporozoea. Sub class: Coccidia. 
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Order: Eucoccidiidae. Suborder: Eimeriina. Family: Eimeriidae. Genus: 
Eimeria. 
 
1.2: Aetiology of poultry coccidiosis: 
Common disease of many species of birds caused by species of 
genera primarily Eimeria and Isospora and are quite host specific in 
chickens: disease of universal importance is Eimeria tenella (caecum), E. 
acervulina (upper small int.), E. maxima and E. necatrix (mid small 
intestine). In turkeys: common, lesions are less severe than in chickens E. 
adenoides (caecum), E. meleagrimitis (mid small intestine). In geese: E. 
truncata and E. anseris. Whereas in ducks: renal coccidia due to E. 
boschadis and in quail, partridges, and pheasants causes by various 
species of Eimeria causes enteritis. Moreover, in quail coccidiosis is 
commonly associated with ulcerative enteritis caused by Clostridum 
colinum (Shivaprasad, 2007). 
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Table (1:1):  
Classification of Eimeria spp. 
Class Sub/class Order Sub-order Family Representative genera  
Perkinsea 
 
Gregarina 
 
Protococcidia 
 
Adelorina 
 
 
 
 
 
 
 
 
 
Agamococcidia 
 
 
 
 
 
 
 
Sporozoea→ 
 
Coccidia→ 
 
Eucoccidia  → 
 
Eimeriina→ 
 
(1)Eimeriidae 
 
Eimeria, Isospora, Cryptosporidium 
 
 
 
 
 
 
 
 
(2)Sarcocystidae 
 
Sarcocystis,Toxoplasma Besnoitia, 
Cystoisospora,Hammondia, Frenkelia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Haemosporiina 
 
 
 
 
Plasmodiidae 
 
 
 
 
Plasmodium, Haemoproteus, 
LeukocytozoonHepatocystis. 
 
 Piroplasmida Piroplasmida  (1) Babesidae 
(2) Theileriidae 
Babesia 
Theileria 
 
Phylum: Apicomplexa Levine, 1970 
Class: Sporozoea leukart, 1879 
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Gerald (2007) mentioned that coccidiosis affects several different 
animal species. In cattle, coccidiosis may produce clinical symptoms in 
animals from 1 month to 1 year of age but is infective to all age groups. 
The group of coccidia that are infective to cattle belong to the Eimeria 
genus. Coccidia are very host specific, that is, only cattle coccidia will 
cause disease in cattle; other species specific coccidia will not cause 
disease. 
Intestinal coccidians from the genus Isospora (Protozoa, 
Apicomplexa) infect a number of songbird species in the wild (Giacomo 
et al. 1997; Duszynski, et al. 2000; McGraw and Hill, 2000). Related 
species (coccidia from the genus Eimeria) are common parasites of 
poultry where they directly inhibit uptake of essential dietary 
components, including carotenoids in the gastrointestinal tracts of 
chickens (Allen 1987, 1997; Allen and Fetterer 2002 a, b). 
Carmichael (1998) reported that there are many protozoa in the 
Subclass Coccidia, but emphasized on the family Eimeriina, in particular, 
the Genus Eimeria. Within the genus Eimeria, there are hundreds of 
different species, which cause disease in mammals, birds and reptiles. 
Each species is identifiable by a particular size and shape, as well as by 
various other distinguishing characteristics. 
 
1.3: Geographic distribution of coccidiosis in poultary:  
Jeffers (1974) propagated coccidia from all major broiler-
producing regions of the United States. The author obtained Eimeria 
tenella from 308 (29.3%) of the farms which yielded coccidia. This 
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species being most prevalent in the southeastern and south-central 
regions.  
Poultry coccidiosis in the Sudan was first reported in 1971 then 
many cases were reported in different regions (Annual Reports of Under 
Secretary for Animal Resources, 1977-1990).  
In Khartoum state incidence the 24% poultry farm which 
distributed in Khartoum, Khartoum North and Umdourman, whereas the 
disease showed highly incidence in Khartoum and Khartoum Bahri 
(Annual Reports under Secretary, Ministry of Agriculture, Animal 
Resources and Irrigation, 2005).  
Mohammed, et al. (1990) reported that five species were identified 
during an outbreak of coccidiosis in a farm in Khartoum. These species 
included Eimeria tenella, E. maxima, E. mivati, E. praecox and E. 
brunette.  
1.4: Coccidian Life Cycle: 
Researchers interested in the Eimeria species continue to analyze 
the intricate details of its life cycle in hopes of alleviating the potential 
hazards (Bruce, 2002). 
As Eimeria species tends to be very specific in the intestinal region 
at which they invade, their life cycles are similar with a degree of species 
specificity (Bruce, 2002). The Eimeria complete their life cycle in three 
distinctive phases including sporogony, merogony, (schizogony) and 
gametogony; however, the lengths of these phases are unique to the 
species (Yun et al., 2000).  
 
 
9
Oocysts is easily transmissible by mechanical means such as 
contaminated footwear and equipment, or it can be found in litter, 
contaminated soil, feed, or water (Conaway and McKenzie, 1991; 
McDougald and Reid, 1997).  
Edgar (1992) mentioned that Coccidiosis, caused by the ingestion 
of microscopic oocysts. Thus chickens can become infected by coccidia 
once the oocysts develop into an infective stage outside of the host. 
Sporogony is the process of a one-celled zygote within the oocyst 
undergoing a series of divisions to form sporozoites, which are contained 
within sporocysts. Only oocysts that have undergone this process are able 
to cause disease. 
Bruce (2002) revealed that the sporulated oocysts contain four 
sporocysts, and each sporocyst contains two sporozoites. Mechanical 
action of the gizzard and pancreatic enzymes such as trypsin and bile 
salts cause the destruction of the oocysts’ outer wall, which releases the 
sporocysts into the digestive tract. Furthermore, the sporocysts are further 
excysed by trypsin and bile salts that are present in the intestine. The 
researcher pointed out that sporozoites invade villus epithelial cells along 
specific locations throughout the digestive tract depending on the species 
of Eimeria. Whereas some species travel within the mucosa, through the 
lamina propria to the crypt epithelial cells. Once inside villus or crypt 
cells, the process of merogony takes place.  
The sporozoite develops into a rounded body called a trophozoite, 
and then into an asexually reproductive first-generation schizont 
(meront). Moreover, the schizont grows and divides rapidly to produce 
many first-generation merozoites; then, the bodies rupture and release 
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hundreds of first-generation merozoites, whichseek out and invade other 
epithelial cells. Second-generation trophozoites develop into second-
generation schizonts. When the second-generation schizonts mature and 
rupture, increased quantities of invasive merozoites are released causing 
widespread infection. The number of asexual stages and time required for 
each depends on the Eimeria species involved; however, most species 
will have less than four asexual reproductive generations (Rose, 1987; 
Edgar, 1992).  
Merozoites produced by the latter schizont generations develop 
into sexual forms called gametocytes, some male and some female. This 
phase of sexual reproduction is termed gametogony. The female 
gametocyte matures into a macrogamete and the male gametocyte 
matures and ruptures releasing a large number of motile, biflagellate 
microgametes. The microgametes penetrate the mature female 
macrogamete and fertilization occurs. Following fertilization, a thickened 
protective wall forms around the zygote. At this stage, the zygote is 
considered an immature oocyst. When mature, the oocysts rupture the 
host cell, enter the lumen, and are expelled into the faeces (Jeurissen, et 
al., 1996; McDougald and Reid, 1997; Yun, 2000). 
The sporulated oocyst is the infective stage of the life-cycle. 
Oocysts can be transmitted mechanically by personnel, contaminated 
equipment, or in some cases, by wind spreading poultry-house dust and 
litter over short distances (Simon, 2007). The author mentioned the 
factors contributing to outbreaks of clinical coccidiosis include:- litter 
moisture content exceeding 30% due to ingress of rain or leaking 
waterers, immunosuppression (Marek’s disease, IBD, mycotoxins), 
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suboptimal inclusion of anticoccidials or incomplete distribution (poor 
mixing) in feed and environmental and managemental stress such as 
overstocking, inoperative feeding systems, insufficient ventilation.  
David (2007) reported that the transmission stage of the parasite is 
a microscopic egg shaped cyst (known as the oocyst). Oocysts are shed in 
the droppings and undergo a process known as sporulation that takes 24-
48 hours; after this the oocyst is infective if ingested by a bird. Therefore, 
an important aspect of the life cycle of these parasites is that the severity 
of the disease is proportional to the number of sporulated oocysts 
ingested.  
Oocysts excreted from the birds remain in the environment and 
have the potential to infect other birds. Under favorable environmental 
conditions (approximately 84°F), sporulation of oocysts is achieved in 24 
to 48 hours, and the cycle will continue (Edgar, 1992; Graat et al., 1994; 
McDougald and Reid, 1997).  
Edgar (1992) reported that once the oocyst is sporulated, it can 
remain infective to birds from several months to one or two years if 
protected from very hot, dry, or freezing conditions. Coccidial oocysts 
have rigid characteristics but are not totally indestructible.  
According to Lee and Shih (1988) unsporulated oocysts are more 
susceptible to physical and chemical agents than sporulated oocysts 
perhaps due to a highly sensitive metabolic state. Moreover, other 
factors, such as ammonia and anaerobic conditions, are also lethal to 
oocysts in the environment. Cessation of development occurs when 
oocysts are introduced to high levels of CO2 or NH4, or exposed to 
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mercury salts, mercuric cyanide, and mercuric chloride due to the ability 
of these agents to penetrate the oocyst wall (Kheysin, 1972).  
The time it takes for oocysts to be seen in the feces after ingestion, 
is approximately 4 to 7 days for the Eimeria species (Henken et al., 1994 
a,b; Jeurissen, 1996; McDougald and Reid, 1997). 
 
1.5: Infection: 
To initiate infection, sporozoites are released, in the gut, from 
ingested sporulated oocysts and invade epithelial cells lining the 
intestine. The entire life cycle occurs in the mucosa and lamina propria, 
and although light infections are often subclinical, heavy infection can 
result in severe weight loss, growth depression, and even death (Long, 
1973). 
It is well established that chickens which survive an initial 
infection are resistant to re-infection (Rose and Long 1962). Such 
immunity is species specific (Rose, 1973) and possibly directed against 
the sporozoite stage (Rose, 1974). 
Morishima et al. (1984) studied the effect of Eimeria tenella 
infection on Salmonella typhimurium infection of chickens was tested 
using feed experimentally contaminated with S. typhimurium. In all 
research experiments, chickens were necropsied 3 to 14 days after E. 
tenella infection. The number of S. typhimurium in the caecal contents 
was counted and the presence of the organism in the liver and bile was 
examined. In Experiments 1 and 2, there was no significant difference in 
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S. typhimurium infection between the group infected with S. typhimurium 
alone and the group infected with both E. tenella and S. typhimurium. In 
Experiments 3 and 4, S. typhimurium counts in the caecal contents of 
chickens in the concurrently infected group were significantly greater 
than those of chickens in the S. typhimurium alone-infected group. 
The specific mechanisms by which each coccidial species causes 
disease is not clear; however, the establishment of secondary infections 
due to the altered intestinal mucosa may be responsible for a differential 
host response (Barker, 1993). This is possible because coccidia are able 
to interact with other pathogens such as bacteria and viruses, which may 
amplify the observed effects (Ruff, 1993). As stated above, the ability of 
the chicken to control the severity of infection and develop protective 
immunity to coccidial parasites depends on numerous factors. Host 
responses to the parasite involve a complex series of internal factors that 
are dependent on developmental stage of the parasite, immune status of 
the bird, and species and strain of the Eimeria parasite. 
Al-Natour et al. (2002) examined parasitological parameters from 
chicks were submitted for post-mortem taken randomly from farms in 
northern Jordan, they were identified seven Eimeria spp.: E. acervulina, 
E. brunetti, E. maxima, E. necatrix, E. mivati, E. mitis, and E. tenella. 
Half (50%) of the farms surveyed had all six chicks infected, 23% of the 
farms were free of the infection. E. tenella was the most prevalent 
species (39%) followed by E. necatrix (12%), E. brunitti (12%), and E. 
maxima (10%). The authors concluded that prevalence did not vary by 
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flock size. Also, neither the use of coccidiostat nor previous coccidiosis 
clinical outbreaks was associated with the prevalence of coccidiosis.  
 
1.6: Pathogenicity of poultry coccidiosis: 
Eimeria spp. differ in their pathogenic effect; it was found in 
caecal coccidiosis due to E. tenella occurs most frequently in young 
birds. On the other hand, Gardiner (1955) pointed out that one to two 
weeks old chickens were more resistant. Older birds generally immue as 
a result of pervious infection. In general clinical caecal coccidiosis is 
produced only when heavy infections are acquired over a relatively short 
period of time, not exceeding 72 hours (Davis and Porter, 1979). 
Shuping et al. (1995) investigated the effect of tumor necrosis-like 
factor (TNLF) on the pathogenesis of coccidiosis. Injection of crude 
chicken TNLF enhanced the weight loss caused by Eimeria tenella 
infection. Rabbit polyclonal antibody against recombinant human tumor 
necrosis factor-a (rhTNF) partially restored E. tenella induced weight 
loss in SC chickens, but not in TK chickens. However, injection of 
chickens with chicken TNLF, rhTNF, and rabbit serum against rhTNF 
had no significant effect on caecal lesions. Whereas in general, 
macrophages from SC chickens produced higher levels of TNLF than 
those from TK chickens. They were observed no significant difference 
between primary and secondary infection. These results suggest that the 
excessive TNF production may be involved in weight loss caused by E. 
tenella infection in SC chickens.  
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In bacteria-free chickens infected with surface-sterilized Eimeria tenella 
oocysts, clinical signs do not develop unlike in chickens with two or more indigenous 
species of bacteria (Radhhakrishnan, 1971; Johnson and Reid, 1972; Visco and 
Burns, 1972a; 1972b). Apparently, indigenous bacteria are required for the 
occurrence of typical caecal coccidiosis in chickens. In the course of development of 
caecal coccidiosis, the growth of Clostridium perfringens and coliforms, especially 
Escherichia coli, is stimulated whereas the growth of Lactobacillus spp. is suppressed 
(Johansson and Sarles, 1948; Radhhakrishnan, 1971). Lactobacillus spp have been 
shown to inhibit the invasion of Eimeria tenella in vitro (Tierney et al., 2004). 
 
1.7: Clinical findings:  
Reduced weight gain is a major contributor to the production 
losses that accompany coccidia infections in young chickens. Because 
inflammatory immune responses divert energy from growth. The clinical 
signs of coccidiosis are associated with tissue destruction from the 
release of the merozoites and mature oocysts from the mucosal surface 
during the last generations of merogony and throughout gametogony. In 
severe infections, much of the mucosal epithelium is sloughed off and 
nutrient absorption is compromised (Jeurissen, 1996; McDougald and 
Reid, 1997; Yun, 2000). 
Schwartz (1994) demonstrated that coccidiosis and its infection 
were one of the most economically important protozoan diseases of 
poultry is coccidiosis, caused by Eimeria spp in intensively reared 
chickens which are in daily contact with their droppings. The disease is 
characterized by enteritis and diarrhea. 
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Eimeria tenella is the cause of caecal coccidiosis in young birds, 
but rarely in those less than ten days old. The disease is characterised by 
the presence of profuse bloody diarrhoea about five days after infection. 
On examination the caeca (blind ending sacs) of the large intestine are 
swollen and filled with a bloody mass; haemorrhagic areas can be seen 
on the lining. In some cases ‘caecal plugs’ form from the accumulation of 
blood, pus, oocysts and faeces. Mortality is often high where treatment is 
not available. Resistance to infection can develop through continued 
exposure, so outbreaks are less common in older birds (Peter, 1996). 
Simon (2007) pointed out that coccidiosis is generally acute in 
onset and is characterized by depression, ruffled plumage, and diarrhea. 
Birds infected with E. tenella show pallor of the comb and wattles and 
blood-stained caecal droppings. He mentioned that the Lesions varies in 
different species  in E. acervulina and E. mivati are 1-2 mm areas of 
hemorrhage interspersed with white foci visible through the serosa of the 
distal duodenum and proximal jejunum. Whereas In E. necatrix are 
severe distention of the mid-jejunum with hemorrhages in the mucosa 
and red-stained fluid in the lumen. Furthermore, in E. maxima are 
distention of the mid-jejunum with hemorrhages in the mucosa. 
Moreover, in E. tenella are hemorrhagic typhlitis. However, in E. 
brunette are hemorrhages of the mucosa of the distal jejunum and colon. 
Fibrinonecrotic enteritis may occur in chronic cases.  
Birds infected with coccidial oocysts do not perform as well as 
non-infected birds as a result of moderate to severe damage to the 
intestinal mucosa. Moreover, birds exhibit decreased weight gains, 
increased feed conversion, and in some cases, birds may appear 
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asymptomatic, but are limited in their ability to maximize feed efficiency 
(Edgar, 1992; Henken et al., 1994a; Yun et al., 2000). According to 
Edgar (1992), it takes only one viable oocyst to establish the presence of 
coccidia in a poultry house. This is possible because of the parasite’s 
reproduction index. Ingestion of one Eimeria acervulina oocyst in the 
infective state has the ability to yield about 72,000 oocysts in one 
complete life cycle (Henken, 1994). 
Eimeria spp. Induce changes in intestinal mucosa, the severity of 
which is related to parasite density and to the location of parasite within 
the mucosa; Ali (1989) studied the infectivity of E. mivati in chicken, he 
cited that the susceptibility to infection increases with age of host and 
with size of infection dose. In other research revieled that injected 
sporozoites of E. acervulina, E. maxima and E. mivati in the caeca of 
checkens produced the infection stages, while E. acervulina and E. 
maxima failed to produce infection, sporozoites of E. mivati invaded the 
walls and the life cycle was completed. Moreover, single and mixed 
infections with E. acervulina, E. maxima and E. mivati indicated that 
mixed infections produced significantly more severe effects on growth 
than single infections (Joyner and Norton, 1983). 
1.8: Diagnosis of coccidiosis in poultary: 
Soulsby (1982) reported that the diagnosis of coccidiosis in 
chickens is best accomplished by a post mortem examination of a 
representative number of birds. Moreover, the diagnosis of faecal 
examination may lead to quite erroneous results. On the other hand in 
some instances the major pathology is produced before oocysts are shed 
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in the faeces and, conversely, the presence of large numbers of oocysts 
may not necessarily indicate a serious pathogenic condition. Thus, with 
E. acervulina, which has a high biotic potential, comparatively larger 
numbers of oocyst are shed per oocyst given than with E. necatrix. 
Furthermore, the accurate identification of the oocysts of various poultry 
coccidian is not easy. All of this may be avoided by a post mortem 
examination. Whereas the location of the major lesion gives a good 
indication of the species of coccidian concentration. Thus, haemorrhagic 
lesions in the central part of the small intestine would suggest E. 
necatrix; those in caecum, E. tenella; those in rectum, E. brunette. The 
author indicated that it is not sufficient to look for oocysts only, since 
these may be found with the regularity in the small intestine or caecum of 
chickens; rather, it is necessary to determine if large number of schizonts 
are present in the subepithelial tissues for the major pathogens, and in an 
epithelial position for the other species.  
Simon (2007) examined the Lesions of E. tenella and E. brunette 
microscopically from intestinal and caecal scrapings reveals oocysts. He 
cited that to confirm a diagnosis in a commercial operation the following 
specimens should be submitted to a laboratory: Intestine from a 
sacrificed, affected bird preserved in 5% potassium dichromate for 
culture and identification of Eimeria spp., intestine showing gross lesions 
in 10% formalin for histological examination, representative feed 
samples for anti-coccidial assay and counting oocysts from litter samples. 
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1.9: Histological and physiological changes:  
A closer look at histological and physiological changes that occur 
during the course of the immune response to coccidial parasites is 
pertinent to understand the specifics of immunity. Responses to Eimeria 
parasites at the intestinal mucosa may be mediated directly by the 
parasite or by the host’s immuno-inflammatory response, which may 
result in changes in the intestinal mucosal morphology (Barker, 1993). 
Therefore, the author revieled that physiological changes related to 
infection have been well documented in experiments with E. acervulina 
(EA) infected chickens. Results indicate that at the level of the intestinal 
mucosa, local and systemic responses to coccidia are mediated in 
different ways.  
It has been difficult to completely understand these protective 
mechanisms due to increases in drug-resistant strains and the complexity 
of the Eimeria species life cycle. On the other hand the past studies have 
measured the severity of coccidiosis on the basis of weight gains, lesion 
scores, cessation of total oocyst output, and humoral and cellular 
responses (Stiff and Bafundo, 1993; Talebi and Mulcahy, 1995). 
However, a closer look at the histological and physiological changes at 
the mucosal level is pertinent to understand the specific nature of this 
immunity.   
Fernando and McCraw (1973) measured the intestinal response to 
a single dose of EA, and infected birds showed a marked increase in total 
mucosal thickness, decreased villus height, and increased crypt length in 
the duodenum and to a lesser extent in the anterior jejunum. The mucosal 
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alterations were the most severe at the height of infection, and a marked 
increase in the rate of replacement of intestinal epithelial cells was 
observed. In addition to an increase in duodenal epithelial cell turnover. 
Allen (1983) noticed an increase in metabolism of mucosal cells in 
the lower intestine, which may enhance compensatory growth and help 
the bird overcome the negative affects of infection on parameters of 
production. Other morphological changes were evident, such as increased 
gut length and increased tissue moisture (edema) in the intestine, which 
were not associated with starvation, but the sole effects of challenge. 
Moreover, changes in gut environment are also evident from challenge, 
such as decreased pH of the infected area (Ruff and Wilkins, 1984) and 
increased feed passage time (Stephens et al., 1974; McKenzie et al., 
1987). These changes in gut homeostasis may alter feed intake, which 
leads to decreased nutrient digestion and absorption, changes in 
metabolism, and overall decreases in weight gains (Adams et al., 1996).  
Interestingly, researchers have contrasting results in experiments 
where weight gains are measured. Stephens et al. (1974) and Adams et 
al. (1996) reported that decreased in weight gains associated with EA 
challenge, while Ogbuokiri and Edgar (1985) and McKenzie et al. (1987) 
showed no significant weight gain differences when compared to non-
challenged controls. This difference in results could be associated with 
several factors such as genetics of the birds, route of challenge 
administration, amount of infective oocysts administered for challenge, 
and strain of EA (Danforth and Augustine, 1989). 
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Additional studies have shown that initial contact of the 
sporozoites with the intestinal mucosa produces an inflammatory 
response including marked cellular infiltration at the site of infection 
(Rose et al., 1979). This infiltrate consists of multiple leukocyte sub-
populations, macrophages, natural killer cells, granulocytes, and 
lymphocytes that could modulate and enhance immune responses; 
therefore, altering nutrient absorption and decreasing weight gains 
(Jeurissen et al., 1996). 
 
1.10.1: Coccidial immunity caused by coccidial infection: 
It is well established that B and T-lymphocytes are involved in 
responses to Eimeria invasion, but there is limited data concerning the 
possible participation of other effector cells, such as mast cells, which 
may participate in protective immunity. It is known that mast cell 
responses contribute to adaptive immunity in mammalian parasitic 
infections (Rose, 1982; Abraham and Arock, 1998), but their 
involvement in chickens has been largely overlooked. However, an acute 
mucosal mastocytophilia response has been reported during secondary 
Eimeria challenge in chickens (Rose et al., 1980). These responses have 
been questioned as to if there was an increase in mast cell numbers or if 
cell migration occurred (Daszak et al., 1993). Mast cells possess distinct 
attributes that support their role in immune responses, but researchers 
have been limited in their ability to accurately describe the presence of 
mast cells during inflammatory responses due to changes in staining 
properties and morphology associated with tissue location and species 
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variation (Yong, 1997). If mast cells are in fact responsible for aiding in 
protective immunity, it is imperative that they are positively identified. 
Microscopic differential counting should indicate significantly elevated 
numbers of mast cells in the small intestine. Until recently, coccidia were 
classified according to morphological, physiological, and behavioral 
characteristics such as those described by Brackett and Bliznick (1950). 
Today, it is known that different isolates within species of Eimeria 
exist (Chapman, 1982). However, little information is available 
comparing the immunogenicity and immunovariability of different 
strains within each Eimeria species. Shirley (1985) described new 
techniques for revealing definitive markers of different strains within the 
same species of Eimeria; however, the differential host response to the 
different strains was discussed in minute detail. Several authors briefly 
state events within their experiments in which different strains were 
noticed (Talebi and Mulcahy, 1995).  
It has been shown recently that extracts from the sporozoites of 
Eimeria tenella containing no viable parasites can be used to successfully 
vaccinate against this infection (Murray, et al., 1986). The effector 
mechanism(s) of protective immunity induced by live infection or by 
extract vaccine remains unclear. Although antibodies from various 
sources demonstrate a variety of anti-parasitic activities, including 
sporozoite immobilization (Herlich, 1965), sporozoite and merozoite 
agglutination and lysis (Crane, 1986; Long and Rose, 1972), 
neutralization (Crane, 1986, Herlich, 1965, Long and Rose, 1972,  Rose, 
1982), and surface changes (Witlock and Danforth, 1982), the role of 
 
 
23
serum antibody in protective immunity is unclear (Joyner  and Norton. 
1974, Rose,1982; Rose and Hesketh 1982; Rose and Long. 1971). 
Recently, emphasis has been directed towards cell-mediated effectors 
(Joyner and Norton. 1974; Rose, and Hesketh 1979; Rose and Hesketh, 
1982) or secretory antibody (immunoglobulin A [IgA]), which has been 
shown to neutralize sporozoites both in vitro and in vivo (Davis, 1978; 
Davis and Porter, 1979). 
William and William (1968) re-examined acquired immunity to re-
infection with Eimeria tenella. They were suggested that chickens, 
immunized by multiple doses of E. tenella, develop only a condition of 
"relative immunity." Immunity, as assessed by clinical signs of the 
disease, lasted some where between 42 and 63 days after the last 
immunizing dose. Immunity, where by the host is protected against fatal 
E. tenella infection, moreover, they found to be effective for at least 105 
days. Complete immunity, where there is no invasion of host tissue, as 
assessed by the presence of un sporulated oocysts in the fecal material of 
challenged immune birds, was not encountered. Although chickens were 
producing serum lysins 21, 42, 63, 84, and 105 days after the last 
immunizing dose, they still remained susceptible to challenge 
inoculations given at that time. 
Bumstead and Millard (1987) exposed 3-week old chicks of 
different breeds and inbred lines of chickens to several Eimeria species 
and measured disease resistance by changes in body weight, mortality 
and oocyst output. The influence of host strain on the response criteria 
was clearly demonstrated. Pinard et al. (1998) found the Egyptian 
Fayoumi to be the most resistant of the five outbred lines tested based 
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upon mortality, lesion scores and growth reduction. Other traits in 5 
which variation among populations in resistance to coccidiosis has been 
expressed include packed cell volume (PCV), and lesion scores (Mathis 
et al., 1984; Martin et al., 1986; Bumstead and Millard, 1987; Lillehoj 
and Ruff, 1987). In general, the various measures of response to Eimeria 
did not correlate with one another. Further, host resistance generally 
depended upon the Eimeria species involved (Bumstead and Millard, 
1987).  
Jeffers (1978) presented data which supported the importance of 
host strain x coccidial species interactions in the expression of host 
susceptibility. According to Mathis et al. (1984) PCV was a better 
measure of disease resistance to E.tenella infection than to E. acervulina 
because, compared to the latter, the former causes extensive hemorrhage 
which substantially depresses PCV. 
The relationship between body weight and lesion scores varies 
among Eimeria species. Conway et al. (1990) observed that lesion scores 
did not fully reflect the degree of disease severity in induced infection. 
Their results corroborated those of Long et al. (1980), in that weight 
changes in susceptible broiler birds infected with E. tenella did not 
correspond with those of immunized birds having similar lesion scores. 
On the other research Long (1973) has suggested that the different results 
obtained by various investigation concerning the pathogenicity of 
Eimeria might be a result of using experimental animals differing in 
genetic resistance to coccidiosis. 
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1.10.2: Immune responses: 
Eimeria parasites exhibit both extracellular and intracellular stages 
of life cycles in their infection of the host. The role of the humoral 
component of the immune system appears to be important during the 
early phase of the infection and circulating antibodies specific for 
coccidial parasites are detectable within one week of inoculation with 
oocysts (Lillehoj, 1991). The level and duration of antibody response 
depends on host factors such as age and genetics of the host, and the 
species of Eimeria (Lillehoj, 1988). However, bursectomy or transfer of 
protection by using Eimeria immune antibodies show that antibodies are 
not involved in host resistance to coccidial challenge infection (Rose, 
1974; Giambrone et al., 1981; Lillehoj, 1987). On the other hand, there is 
extensive evidence which shows that cell-mediated immune responses 
are essential in limiting oocyst production in primary and subsequent 
infections (Wakelin and Rose, 1990; Lillehoj and Trout, 1993; Ovington 
et al., 1995). Generally, antigens of the various Eimeria species vary in 
immunogenecity, with E. maxima and E. brunetti being the more 
immunogenic whilst E. necatrix and E. tenella are the less immunogenic 
(Ovington et al., 1995). The antigenic determinants of the different 
species are not cross-reactive (Wallach et al., 1990). Thus Bumstead and 
Millard, (1992) noted that chickens from lines which produced the largest 
numbers of oocysts following infection with E. tenella produced the 
fewest number when infected with E maxima, E. mitis, or E. praecox. 
Within Eimeria species, immunogenecity also varies between stages of 
development, the asexual stage being more immunogenic than the sexual 
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stage (Rose and Hesketh, 1976). Even though coccidial merozoite 
antigens that induced T-cell proliferation were ssociated with resistance 
to infection (Jenkins et al., 1998), merozoite fractions that induced 
lymphocyte proliferation were different from those that induced 
interferon (IFN-() production, indicating that different antigens favor 
different cellular responses (Martin et al, 1995). Earlier studies (Prowse 
and Pallister, 1989) have shown that interferons (IFN) play a role in 
resistance to primary infection which may be population dependent 
(Ovington et al., 1995). 
Eimeria reside outside the host for part of their life cycle but, the 
majority of it is completed inside the host during asexual and sexual 
stages of development occurring inside or outside enteric tissues. Once 
the bird ingests the viable oocyst(s), a cascade of events occurs involving 
both non-specific and specific defense mechanisms of immunity (Lillehoj 
and Lillehoj, 2000). It is to be expected that the mechanisms responsible 
for immunity are complex due to the complexity of the parasite life cycle. 
Despite all of the research completed on immunity to Eimeria, no clear 
picture has emerged as to how complete resistance is acquired and which 
mechanisms are sequentially involved in generation of immunity (Rose et 
al., 1979; Danforth and Augustine, 1989). 
In naive chickens, those previously unexposed to Eimeria, 
coccidial infections induce a variety of pathological and immunological 
responses, which help the host defend against the parasite and acquire 
protective immunity. However, the level of protection each facet of the 
immune system provides may vary with the developmental stage of the 
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parasite (Rose, 1987). Prior to the generation of a specific immune 
response, the host tries to exclude the Eimeria through non-specific 
immune pathways such as competitive exclusion by normal flora, 
lysozymes, increased gastric secretions, and peristalsis to quickly flush 
parasites from the digestive tract (Lillehoj and Lillehoj, 2000; Yun et al., 
2000). However, it has been reported that these innate defenses as well as 
specific immunologically mediated defenses play a role at the intestinal 
mucosal surface during Eimeria invasion (Lillehoj and Trout, 1993). 
Therefore, the naïve host probably does not eliminate the parasite 
utilizing only nonspecific pathways, but infection can be controlled to a 
certain degree prior to the completion of the Eimeria life cycle and 
generation of a specific immune response. 
 It has been determined that Eimeria parasites are vulnerable to the 
host immune system at three distinct phases of their development: 1) the 
period between excystation and sporozoite penetration of epithelium, 2) 
once the sporozoite enters the host epithelium and is exposed to intra-
epithelial lymphocytes, and 3) during transport of the sporozoite from the 
surface enterocyte, through the lamina propria and into the crypt 
epithelium. After these stages in the life cycle, direct interaction between 
the parasite and cells of the host immune response are unlikely, and the 
probability of intervention is ceased (Jeurissen et al., 1996). 
Stiff and Bafundo (1993) showed the conflicting results in a series 
of experiments that proved complete immunity can and does exist when 
birds are continuously challenged on a daily basis with homologous 
Eimeria challenge. Nevertheless, protective immunity hinders fecal 
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oocyst production, and invasion of the mucosal epithelium is altered. 
Interestingly, in immune birds, sporozoites penetrate the villus 
epithelium but are incapable of reaching the crypt epithelium and 
prevented from further development (Rose et al., 1984; Jeurissen et al., 
1996). 
1.10.3: Mode of inheritance of coccidiosis in poultary: 
Champion (1954) concluded that after a comparison of the survival 
rate of parental lines (resistant and susceptible), F , 1 F , and their 
backcrosses exposed to E. tenella, that sex- 2 linkage, maternal effects or 
cytoplasmic inheritance did not influence susceptibility to E. tenella. His 
lines which had been selected for only two generations did not show 
significant evidence of dominance.  
In a diallel crossing experiment involving nine lines, heterosis of 
up to 34% was observed in the survival rate of some individual crosses 
exposed to E. tenella (Jeffers et al., 1970). Differences in reciprocal 
crosses were attributed to maternal effects. The importance of maternal 
effects in resistance to Eimeria spp was confirmed by Buvanendran and 
Kulasegaram (1972) who tested male progeny of 4 strains crossed 
reciprocally. According to Smith et al. (1994), maternal antibodies 
transmitted early immunity against E. maxima which lasted for 2 to 3 
weeks.  
In two separate experiments in which three different inbred lines 
were crossed, female cross line chicken had significantly greater survival 
rates than male chicks (Jeffers et al., 1970) suggesting involvement of the 
W-chromosome of the dam lines in genetic resistance to E. tenella.  
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1.11: Isolation of Eimeria spp.: 
Tomley (1997) worked on the isolation of E. tenella from the 
apical organelles; which contain molecules that are of critical importance 
for the interaction of all apicomplexan parasites with their target host 
cells. Thus, there is considerable interest in characterizing and 
understanding the function of molecules that reside in these organelles. 
Large numbers of surface-sterilized oocysts of Eimeria tenella, an 
apicomplexan coccidian of the chicken, can be routinely obtained from 
the bird host, and invasive sporozoites, which contain abundant apical 
organelles, can be rapidly prepared from these oocysts in the laboratory. 
Thus, E. tenella is proving to be an amenable parasite for sub-cellular 
fractionation techniques that allow the direct isolation and 
characterization of apical organelles.  
1.12: Control and vaccination: 
David (2007) mentioned that management of the coccidiosis 
disease requires the adoption of sanitary and hygienic procedures to 
reduce the level of exposure to infection. Sporulation is favored by 
moisture. Thus, it is important to maintain dry litter, especially around 
drinkers and feeding areas. Maintaining dry litter will reduce oocyst 
numbers and the likelihood that birds will be exposed to parasite numbers 
that will cause clinical coccidiosis.  
It has been shown that different strains are capable of having 
antigenic diversity, so that the immunity conferred by one species strain 
does not completely protect chickens against further challenge with a 
different strain of the same species (Talebi and Mulcahy, 1995). In 
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reviews on the use of coccidial vaccines by Danforth and Augustine 
(1989)  they were stated that isolates from different geographical areas do 
not always show cross-protection following oral immunization. This may 
be a challenging factor in producing specific vaccines for coccidial 
control. Additional studies need to be conducted to evaluate the 
variability in the host’s protective immune response to different strains. 
This will expand opportunities for the development of alternative control 
measures; however, it is possible that the coccidia may find new ways to 
alter their antigenicity. 
Historically, coccidial parasites have been controlled through the 
use of in-feed coccidiostats. However, through the years, drug-resistant 
strains of Eimeria have emerged, which hinder the efficacy of the 
presently used coccidiostats. Coccidial infections induce a variety of 
pathological and immunological responses which help the host defend 
against the parasite and acquire protective immunity. In addition, it has 
been reported that both immunologically mediated and non-
immunological defenses play a role at the intestinal mucosal surface 
during Eimeria invasion (Lillehoj and Trout, 1993). 
Watkins et al. (1995) attempted to vaccinate broiler chickens 
against Eimeria maxima by in ovo injection of live oocysts or sporocysts 
at 17 to 18 days of embryo incubation. Although they found evidence of 
infection in the newly hatched chicks, these birds showed no protective 
immunity when challenged at 10 days of age. Furthermore, Provaznikova 
and Bedrnik (1997) reported successful immunization of broilers with an 
egg-adapted strain of E. tenella by in ovo administration of sporozoites, 
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although this method was unsuccessful for other species of coccidia 
tested. 
Sousby (1982) cited that the preventive medication of coccidiosis 
consists of prolonged or continuous use of coccisostatic compounds in 
the water or feed. These drugs include amprolium, buquinolate, 
decoquinate, clopidol, momensin, robeniine, zoalene, nicarbazin, 
furazolidone, nitrofurazone, sulphaaquinoxaline, methyl benzoquate and 
salinomycin at the concentrations 0.0125, 0.00055, 0.003, 0.0125, 
0.0121, 0.003-0.006, 0.0125, 0.0125, 0.0055, 0.005-0.01, 0.0125, 0.001-
0.002, 0.005-0.0075 and 0.006-0.01%, respectively. 
 David (2007) mentioned that the control of coccidiosis has been 
achieved by the use of drugs that kill the parasite before it can develop in 
the chicken. In the 1950’s and occasionally today, drugs were often 
included in the drinking water to treat sick birds. Unfortunately the onset 
of coccidiosis is rapid and the signs of disease (such as huddling, ruffled 
feathers, off feed) are seen with many other poultry diseases. The 
researcher concluded that the treatment often came too late to prevent 
serious production losses. A preventative approach is therefore desirable 
and this is achieved by incorporation of drugs in the starter and grower 
feeds. The most widely used drugs are known as ionophores. These 
compounds inhibit the development of the parasite but, do not prevent 
the acquisition of natural immunity by the bird so that they can be 
withdrawn from the feed well before the birds are sold.  
Williams (2002) studied the establishment and use of live 
vaccines, either attenuated or non-attenuated, for the control of 
coccidiosis due to Eimeria infections in broiler breeder or layer chickens. 
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Use in broilers, however, has been slow to gain acceptance. Furthermore, 
this has been partly for economic reasons, but also because of perceived 
adverse effects on early chick growth, particularly with non-attenuated 
vaccines, and concerns about timely onset of protective immunity in such 
short-lived  
David (2007) reported that an entirely different approach to the 
control of coccidiosis involves the use of vaccines. Which birds are 
administered small numbers of sporulated oocysts have long been 
available in the USA. On the other hand in the past vaccines have 
principally been employed during the rearing phase of egg-laying birds. 
The author mentioned that the introduction of novel methods of 
administration (such as with a spray-cabinet in the hatchery) has made 
vaccination of broilers more feasible. Researchers are actively seeking 
better means to safely immunize birds against coccidiosis and although 
there are many technical hurdles to overcome, progress is being made 
and new vaccines seem likely in the future. 
Currently, drugs and live vaccines are the 2 main control measures 
for the disease; however, due to increasing problems with prolonged drug 
usage and the high cost of vaccines, alternative strategies are needed for 
more effective and safer control of coccidiosis in chickens (Dalloul and 
Lillehoj, 2006; Williams, 2006). 
Recent evidence that various dietary and microbial supplements 
can influence host immunity against enteric diseases prompted us to 
investigate the role of a commercial probiotic (MitoGrow, Imagilin 
Technology LLC) on coccidiosis. This probiotic consists of live 
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Pediococcus acidilactici, which belongs to the homofermentative gram-
positive bacteria, able to grow in a wide range of pH, temperatures, and 
osmotic pressures, and thus able to colonize and inhabit the digestive 
tract (Klaenhammer, 1993). 
1.13: Coccidiostat and growth promoters: 
It is controlled by chemotherapy using anticoccidial drugs (synthetic 
products or antibiotic ionophores) in feed. The appearance of resistance 
to coccidiostats, consumer demand for fewer feed additives, and 
European Union regulations (withdrawal of antibiotic feed additives as a 
precautionary measure) might restrict the use of coccidiostats in the 
future. If this happens, methods of production, management, and hygiene 
will be changed. Therefore in the absence of anticoccidial vaccines that 
are not yet generally available in broiler production or to complement 
their action, feed composition, or presentation may be used as an 
alternative to help control coccidiosis. Several dietary supplements such 
as vitamins, n-3 fatty acids, and plant extracts have been reported to have 
beneficial effects (Allen et al., 1998; Banfield and Forbes, 1999; 
Cre´vieu-Gabriel and Naciri, 2001).  
Elwinger et al. (1998) mentioned the removal of antibiotic growth 
promoters is anticipated to result in a significant increase in the incidence 
of necrotic enteritis due to their direct effect on control of the causative 
organism, Clostridium perfringens. The disease is most often established 
after an incidence of coccidiosis. Moreover, the researchers observed 
Eimeria species most commonly associated with necrotic enteritis seem 
to be E. acervulina, E. maxima and to some extent E. necatrix. Finn feeds 
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own necrotic enteritis model simply challenges the birds with E. maxima 
and necrotic enteritis spontaneously develops. 
It is expected that in the near future the coccidiostatics currently used 
in animal feeds will be banned. Thus there is a need for alternative agent 
to control coccidiosis in poultry (Iji et al., 2001). Coccidiostats may 
improve gut health as indicated by increased villi height, uniformity and 
integrity (Loddi et al., 2002) and they modulate gut and systemic 
immunity (Ferket et al., 2002). 
Riddell and Kong (1992) reported that under normal circumstances, 
nitrogen is well digested, little enters the caeca and necrotic enteritis is 
uncommon. However, when viscous diets are fed or coccidiosis increases 
small intestinal damage, excessive quantities of nitrogen escape digestion 
and enters the caeca resulting in a more frequent occurrence of necrotic 
enteritis. Moreover, sloughed cells from damaged villi will provide 
nitrogen to the caeca in addition to the undigested feed. It is thus evident 
that E. tenella may not so readily precipitate necrotic enteritis since, 
although it will provide damaged caecal enterocyte nitrogen to the caeca, 
it does not affect digestion in the small intestine. Reducing the damage 
that coccidiosis causes to the small intestine is essential if nitrogen 
digestibility is to be maintained and necrotic enteritis minimized. 
Betaine improves the osmotic condition of the enterocyte (Allen et 
al. 1998), and when fed with a coccidiostat it appears to reduce the 
incidence and severity of coccidial lesions thus improving animal 
performance.  
Milan and Janet (2005) revealed that betaine per se had no direct 
effect on lesion score in isolation. In the presence of a coccidiostat, 
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however, it is apparent that improving the osmotic status of the gut 
epithelium through addition of betaine results in further reductions in 
lesion scores. In other reported studies, betaine plus salinomycin 
significantly inhibit invasion of both E. tenella and E. acervulina. 
However, subsequent development of E. acervulina is inhibited more 
effectively than that of E. tenella. (Augustine et al.,1997). Recent work 
(Waldenstedt et al., 1999) showed no interaction between narasin and 
betaine in birds which had been inoculated principally with E. tenella and 
E. acervulina. 
Even before 1907 fundamental discoveries on drug resistance in 
trypanosomes, it was know that bacteria and protozoa could be adapted 
to grow and survive in normally toxic concentrations of chemicals by 
repeatedly exposing the organisms to sub-lethal and increasing 
concentrations of compounds. Moreover, drug resistant did not become 
an important practice problem, however, until the development and wide 
spread use of sulfonamide and antibiotics. Furthermore, Sulfaquinoxaline 
has been in continuous and satisfactory use since 1947 for controlling 
coccidiosis in a typeical New England poultry farm and there was no 
evidence that drug resistance has developed in the coccidian. 
Nevertheless, early in 1951, the laboratory studies were began and 
determine whether resistance could be induced in coccidian by repeated 
exposure to suboptimal dosages of anticoccidial agents. A short time 
later, studies were also begun on field strains coccidian.these were 
obtained from poultry farms where due to intercurrent diseases and other 
difficulties anticoccidial medication appeared less effective than 
normally. A strain of caecal coccidian obtained from poultry houses in 
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which nitrofurazone have been used for three years was fully susceptible 
to this drug. On the other hand, the caecal coccidia from an area where 
sulfaquinoxaline had been employed for about for years were fully 
susceptible to this anti-coccidial agents. It was concluded that there was 
no evidence of drug fastness in these coccidia (Ashton and Christine, 
1955). 
Removal of antibiotic growth promoters is likely to increase 
variability in broiler performance. When unrestrained intestinal 
microfloral populations are combined with undigested feed substrates, 
their numbers will increase substantially. The poorer the quality 
(digestibility) of the feed and the greater the microbial challenge 
(environment) the greater this problem will be (Waldenstedt et al., 1999). 
1.14: Mode of action of experimental medications: 
Williams (1997) investigated the anti-coccidial mode of action of 
quinolones (6-decyloxy-4-hydroxyquinoline-3-carboxylates) against 
Eimeria tenella and E. acervulina in chickens. Lower concentrations of 
quinolones allowed sporozoites to continue their development. Whereas 
first-stage schizonts were susceptible to a secondary cidal effect, 
although later schizonts seemed to be rather refractory. Furthermore, the 
sporulation of oocysts produced by E. tenella that completed its life cycle 
in the presence of suboptimal concentrations of quinolones was inhibited: 
this probably reflects a drug effect on gametocytes. The researcher 
reported that quinolones were absorbed rapidly from the chicken 
intestine, probably in less than 1 hour, whereas the drug withdrawal 
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experiments showed that quinolones persisted in chicken tissues at active 
concentrations for up to 48 hour despite their static effect on sporozoites, 
they may nevertheless be expected to exert a therapeutic effect against 
drug-sensitive coccidia in interrupted régimes that allow the later cidal 
effect to come into play. This allows immunity to coccidiosis to develop 
in the presence of drug.  
Artesunate is a semisynthetic derivative of artemisinin, the active 
principle of Artemisia annua L. ART and other artemisinin derivatives are 
promising novel drugs in the treatment of malaria (Price, 2000). They are 
recommended by the World Health Organization as salvage treatment 
options for otherwise unresponsive Plasmodium falciparum and Plasmodium 
vivax strains. Large clinical studies with malaria patients have shown that 
ART is well tolerated, with few and insignificant side effects (Hien, et 
al., 1992). In addition to the well known antimalarial activity of ART, 
Efferth, et al., (2001) identified a profound cytotoxic action of ART 
against cancer cell lines of different tumor types. 
There is no consensus regarding the mechanism through which 
artemisinin derivatives kill the parasites ( Kappe, et al. 2009). Their site 
of action within the parasite also remains controversial. At the chemical 
level, one theory states that when the parasite that causes malaria infects 
a red blood cell, it consumes hemoglobin within its digestive vacuole, 
liberating free heme, an iron-porphyrin complex. The iron reduces the 
peroxide bond in artemisinin generating high-valent iron-oxo species, 
resulting in a cascade of reactions that produce reactive oxygen radicals 
which damage the parasite leading to its death (Cumming, et al. 1997).  
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Numerous studies have investigated the type of damage that 
oxygen radicals may induce. For example, Pandey et al. (1999) observed 
inhibition of digestive vacuole cysteine protease activity of malarial 
parasite by artemisinin. These observations were supported by ex vivo 
experiments showing accumulation of hemoglobin in the parasites treated 
with artemisinin and inhibition of hemozoin formation by malaria 
parasites.  
Electron microscopic evidence linking artemisinin action to the 
parasite's digestive vacuole has been obtained showing that the digestive 
vacuole membrane suffers damage soon after parasites are exposed to 
artemisinin (Del, et al. 2008). This would also be consistent with data 
showing that the digestive vacuole is already established by the mid-ring 
stage of the parasite's blood cycle, a stage that is sensitive to artemisinins 
but not other antimalarials (Abu-Bakar, et al., 2010). 
Li et al. (2005) investigated the mode of action of artemisinin using a 
yeast model demonstrated that the drug acts on the electron transport 
chain, generates local reactive oxygen species, and causes the 
depolarization of the mitochondrial membrane.  
Sulfadoxine or sulphadoxine is an ultra-long-lasting sulfonamide 
often used in combination with pyrimethamine to treat or prevent 
malaria.  It is also used, usually in combination (fansidar is US brand 
name) with other drugs, to treat or prevent various infections in livestock. 
Both drugs are antifolates; they inhibit the production of enzymes 
involved in the synthesis of folic acid within the parasites. Either drug by 
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itself is only moderately effective in treating malaria, because the parasite 
Plasmodium falciparum may be able to use exogenous folic acid, i.e. 
folic acid which is present in the parasite's environment, while in 
combination, the two substances have a synergistic effect which 
outbalances that ability(Toby, et al., 2007). 
Sulphadoxine and pyrimethamine combination is an antimalarial 
agent which acts by reciprocal potentiation of its two components, 
achieved by a sequential blockade of two enzymes involved in the 
biosynthesis of folinic acid within the parasites. Moreover, Sulphadoxine, 
like other sulphonamides, is a structural analog of p-aminobenzoic acid 
(PABA) and competitively inhibits dihydrofolic acid synthesis by 
inhibiting dihydropteroate synthetase, which is necessary for the 
conversion of PABA to folic acid. On other hand pyrimethamine is a 
folic acid antagonist and has a mechanism of action similar to that of 
trimethoprim. By binding to and reversibly inhibiting dihydrofolate 
reductase, pyrimethamine inhibits the reduction of dihydrofolic acid to 
tetrahydrofolic acid (folinic acid). Pyrimethamine interferes with the 
synthesis of tetrahydrofolic acid in malarial parasites at a point 
immediately succeeding that where sulphonamides act (Jeffrey, et al., 
1984).        
1.15.1: Treatment: 
Birds medicated with roxarsone and in another experiment with 
zoalene in the feed produced higher oocyst counts than unmedicated 
control birds receiving the same oocyst dose of Eimeria tenella or a 
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mixture of six species (E. tenella, E. necatrix, E. brunetti, E. maxima, E. 
acervulina, and E. mivati). These experiments confirm the conclusion 
that oocyst counts constitute an unsatisfactory and unreliable parameter 
for judging effectiveness of an anticoccidial even though such increases 
are a relatively rare occurrence in anticoccidial evaluation experiments 
(Malcolm, 1975). 
A wide variety of drugs is available for the treatment of 
coccidiosis. Sulphonamides are still the most frequently used drugs, 
singly or in combination with other drugs such as amprolium and the 
pyrimidines. Frequent use of drugs has led to widespread drug resistance 
(Peter, 1996).  
Jeffers (1974) found that the incidence of E. tenella was high in 
flocks medicated with Nidrafur or Zoamix, and much lower in flocks 
medicated with Amprol Plus, Bonaid, Coyden, or Deccox. Tests of 201 
of the E. tenella isolated showed that their drug sensitivity had been 
reduced by field exposure to the anti-coccidials. Moreover, reciprocal 
cross-resistance to Bonaid and Deccox was high among the quinoline-
resistant isolants. He concluded that the distribution of multiple drug-
resistance phenotypes among the E. tenella isolants emphasized a 
complete drug-resistance profile of strains of coccidia is necessary for 
determining the anticoccidial drug(s) that would control them most 
effectively.  
Simon (2007) recommended that the administration of amprolium 
solution or sulfonamides (sulfamethazine or sulfaquinoxaline) in drinking 
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water. In addidtion to the administration of water dispersible vitamin A 
and K supplements may enhance recovery of chicken from coccidiosis.  
Du and hu (2004) studied a liquid and a powder made from a herbal 
complex consisting of Uncariae Ramulus cum Uncis, Agrimoniae Herba, 
Sanguisorbae Radix, Eclipta Prostrate Herba, Pulsatillae Radix, Sophorae 
Flavescentis Radix, Rehmanniae Radix and Glycyrrhizae Radix their 
anticoccidial activities in chickens. They were administered Chickens 
with herbal liquid, powder, diclazuril or without medication during the 
study and challenged with oocysts of Eimeria tenella. Their results 
indicated that the birds medicated showed less bloody faeces than those 
without medication. Moreover, the intestinal lesion was mild in the 
chicks medicated with herbal liquid without significantly different lesion 
score when compared with uninfected chicks. The birds with medication 
had significantly higher body weight gains than birds without 
medication. Therefore, they were concluded that the herbal complex was 
effective against E. tenella infection in chickens. 
Reid (1975) has reviewed that the progress in the control of 
coccidiosis with anticoccidial drugs. He estimates that new compounds 
continue to be introduced to the poultry on an average of about one every 
two years. In general, mortality due to coccidiosis can be eliminated by 
any of the 25 or more approved anti-coccidial drugs if they used 
properly. Thus, anti-coccidial drugs are used usually in starter rations for 
meat-type birds raised under floor-open management. Whereas 
protection is more important with these fast-growing birds than he egg-
production types, where immunity and caging alter the demand for anti-
coccidial drugs. However, selection for of an anti-coccidial is based on 
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the ability of the drug to improve weight and feed conversion and to 
suppress the development of lesions. 
The methods used to avoid the development of drug resistant include 
switching around 13 classes of drugs and the shuttle program, which is a 
planned switch of the drug in the middle of the growing period of the 
birds (Reid, 1975). The speed of emergence of resistant strains of 
coccidian in the field is given by Reid (1975) which were glycomide -
very rapid-; quinolines (buquinolate, deconquinate, nequinate) –rapid; 
clopidol –less rapid; sulphonamides, nitrofurans, robenidine –moderatte; 
amprolium, zoalene, nitromide –slow; nicarbazin –very slow; monensin –
absent or very slow. 
 Sousby (1982) pointed out that the anti-coccidial drugs dealt with 
various regulations apply to the pre-market withdrawal of the drug, 
although some compounds are classed as no-withdrawal which is often 
substituted for a withdrawal anti-coccidial during the final days before 
marketing.  
Sousby (1982) mentioned that the curative treatment should be 
instituted immediately after a diagnosis of coccidiosis is made. 
Furthermore, an interrupted form of treatment is more satisfactory with 
the sulpha drugs than continuous treatment, which aims to avoid undue 
concentrationsof the compounds which inhibit the earlier developmental 
stages of the parasite and thus interfere with the acquision of immunity. 
To avoid this, Daivies and kendell (1954 a,b) suggested given sodium 
sulphadimidine, sodium sulphaquioxaline and nitrofurazone wih 
furazolidone at concerations 0.2 m 0.5 and 0.0126%, respectively. 
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In some cases, birds are given one drug, but two or more drugs (so-
called shuttle programs) may be given during the life of a flock. It is 
convenient to provide a particular compound for a period during which 
one type of feed is given (Chapman1, 2001). 
1.15.2: Anti-malarial Medications used in the Treatment of 
Coccidiosis: 
 The well known ant-malarial agents, pamaquine (8-(4-
diethylamino-1-methylbutylamino)-6-methoxyquinoline) was 
synthesized by the modification of the dye methylene blue about 60 years 
ago and was first synthetic drug applied to the treatment of malaria 
(Schuhlemann, 1932). Attempts to lessen the hemolytic adverse effect 
pamaquine result in the synthesis of primaquine, the safer and more 
potent 8-aminoquinoline compound (8-(4-amino-1-methylbutylamino)-6- 
methoxyquinoline) (Edgcomb, et al., 1950). This drug had been used 
until the 1960's when the resistance of the parasite to the drug developed 
frequently (Thompson and Werbel, 1972).  
 Pamaquine and primaquine are used in the field of veterinary 
medicine for treatment of bovine prioplasmosis. Further, primaquine's 
activity against Sarcocystis muris was found recently (Rommel, et al., 
1981).  
 Toshimi et al. (1991): investigated the activity of anti-malarial 
drugs pamaquine and primaquine against a laboratory strain of E. tenella, 
E. necatrix, E. acervulina, E. maxima and E. brunetti revealed that both 
drugs were effective against E. tenella and E. necatrixbut not against an 
other three species. Whereas pamaquine suppressed the symptoms of E. 
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tenella at the concentration above 125 ppmin feed. Moreover, primaquine 
controlled the clinical signs at level above 31.5 ppm. Furtheremore, the 
activity against E. necatrix was observed with pamaquine at 250 ppm and 
with primaquine at level above 125 ppm. On the other hand pamaquine 
showed tendency apparently to reduce body weight gain at 125-500ppm, 
whereas primaquine showed the same tendancy at 500 ppm. 
1.15.3: Biotechnologies of exeperimental medications: 
Artesunate is an antimalarial agent. It is a water-soluble 
hemisuccinate derivative of dihydroartemisinin. Artemisinin is a 
sesquiterpene lactone isolated from Artemisia annua, a herb that has 
traditionally been used in China for the treatment of malaria. Artesunate 
and its active metabolite dihydroartemisinin are potent blood 
schizonticides, active against the ring stage of the parasite. Artesunate is 
ideal for the treatment of severe malaria, including cerebral malaria. It is 
also active against chloroquine and mefloquine resistant strains of P. 
falciparum. It is unstable in neutral solution and is therefore only 
available for injections as artesunic acid. The injectable formulation must 
be prepared immediately before use in 5% (w/v) sodium bicarbonate 
solution to produce the salt sodium artesunate (Taylor et al., 2000). 
Artemisinin also known as qinghaosu, and its derivatives are a 
group of drugs that possess the most rapid action of all current drugs 
against falciparum malaria (White, 1997). Treatments containing an 
artemisinin derivative (artemisinin-combination therapies, ACTs) are 
now standard treatment worldwide for falciparum malaria. The starting 
compound, artemisinin (a sesquiterpene lactone), is isolated from the 
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plant Artemisia annua, a herb described in Chinese traditional medicine, 
though it is usually chemically modified and combined with other 
medications. Moreover, use of the drug by itself as a monotherapy is 
explicitly discouraged by the World Health Organization as there have 
been signs that malarial parasites are developing resistance to the drug. 
Combination therapies that include artemisinin are the preferred 
treatment for malaria and are both effective and well tolerated in patients. 
The drug is also increasingly being used in vivax malaria (Douglas et al., 
2010) as well as being a topic of research in cancer treatment (Douglas et 
al., 2010). 
Artemisinin was isolated by Chinese scientists in 1972 from 
Artemisia annua (sweet wormwood), better known to Chinese herbalists 
for more than 2000 years as Qinghao. In the early 1970s, initial testing by 
Chinese scientists of Qinghao extracts in mice infected with malaria 
showed it to be as effective as chloroquine and quinine in clearing the 
parasite. Mao Tse Tung’s scientists then began testing in humans and in 
1979 published their findings in the Chinese Medical Journal. 
Artemisinin and other artemether-group drugs are currently the main line 
of defense against drug resistant malaria in many parts of South-East 
Asia. To date there have been no reported cases of resistant to 
artemisinin. Artemisinin is today a very potent and effective antimalarial 
drug, especially when used in combination with other malaria medicines. 
Its available in tablets, capsules, injection (Taylor et al., 2000). 
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Fansidar is an antimalarial agent, each tablet containing 500 mg 
N1-(5,6-dimethoxy-4-pyrimidinyl) sulfanilamide (sulfadoxine) and 25 
mg 2,4-diamino-5-(p-chlorophenyl)-6-ethylpyrimidine (pyrimethamine). 
Each tablet also contains cornstarch, gelatin, lactose, magnesium stearate 
and talc.It is only used in certain circumstances because resistance to this 
treatment is high. 
Pyrimethamine or fansidar is used in the treatment of 
uncomplicated malaria. It is particularly useful in cases of chloroquine-
resistant P. falciparum strains when combined with sulfadoxine. It acts 
by inhibiting dihydrofolate reductase in the parasite thus preventing the 
biosynthesis of purines and pyrimidines, thereby halting the processes of 
DNA synthesis, cell division and reproduction. It acts primarily on the 
schizonts during the erythrocytic phase, and nowadays is only used in 
concert with a sulfonamide (Baird et al., 2003).  
Primaquine (or primaquine phosphate) is a medication used in the 
treatment of malaria and Pneumocystis pneumonia. It is a member of the 
8-aminoquinoline group of drugs that includes tafenoquine and 
pamaquine (Mihaly et al., 1985). Moreover, Primaquine is mainly used 
to treat the P. vivax or P. ovale malaria. Once the parasite has been 
eliminated from the bloodstream, the remaining hypnozoites must be 
removed from the liver and this is done by administering a 14 day course 
of primaquine (Baird et al., 2003). This process is called a radical cure. If 
primaquine is not administered to patients with proven P. vivax or P. 
ovale infection, there is a very high likelihood of relapse within weeks or 
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months (sometimes years). When attempting a radical cure, primaquine 
requires the presence of quinine or chloroquine in order to work (Alving 
et al., 1955). If primaquine is given alone, the cure rate is only 21%. It is 
not known if other antimalarials such as mefloquine are likewise able to 
potentiate the effect of primaquine. Primaquine is not routinely used to prevent 
malaria in travelers, and is only used as such when no other alternatives are 
appropriate (Hill et al., 2006).   
Primaquine is the recommended prophylactic agent by the Centers for Disease 
Control and Prevention (CDC) in some instances. Moreover, primaquine is an 
antimalarial drug. The exact way that primaquine works is unknown. 
Primaquine is used to treat and prevent malaria (Centers for Disease Control 
and Prevention, 2005). 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1. Collection of E. tenella samples: 
A total of 1500 caecal samples were collected on ice from chickens 
Bovans in Khartoum State. 
 
2.2. Experimental infection: 
Three hundred one-day-old male Hisex brought from Koral Farms 
were reared in Shambat in pen of Faculty of Veterinary Medicine until 
the age of three weeks, then placed in fourteen different pens which were 
classified into four groups: infected with treatment (treated group), 
infected without treatment (infected control), not infected not treated 
birds (naive) and not infected treated. Whereas, the first two groups was 
orally challenged with artificial infection E. tenella sporulated oocysts 
doses. The first two groups was have been given 1×104 sporulated 
oocysts of E. tenella. Therefore each bird was inculated by stomic tube 
on chickens crops. 
 
2.3. Experimental treatment and administered doses: 
The starter feed with non anti-coccidial additives was offer then 
medications were mixed with water for the four treatments whiched the 
treatment by primaquine had three levels. The experiment started after 
the third day of infection i.e. 24 days-old. The birds were thirest a half of 
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a day then water mixed with medications were offered. The exposure to 
the sun light was avoided in order to ensure the constituents conservation 
of the drugs under test and feed ingredients. 
The treated experimental birds were separated into seven groups 
according to the type of medications primaquine, artesunate and fancedar 
(anti-malarial drugs). Whereas, amprolium acted as anti-coccidial 
medication, level of the drugs 31.2, 125 and 250 ppm for primaquine 
group, whereas artesunate 33 mg and fancedar 86.625 mg. The anti-
coccidial drug amproluim have got one level 60 grams per 100 liters 
water which was recommended on database. The subgroup was consisted 
of twenty birds for each. 
 
2.4. Experimental parameters and data collection: 
Parameters studied included body weight gain, the cumulative feed 
intake, the feed conversion ratio, the survival rate, the lesion score, 
bloody diarrhoea proportion, diseased and survival chicks, survival time, 
clinical symptoms, causes of mortality. (No. of died birds divided by No. 
of total birds all multiplied by 100), and the oocyst per gram (OPG). liver 
function tests which include serum calcium sodium, potassium, iron, total 
bilirubin (TBIL), total protein, albumin, alkaline phosphorus, alkaline 
phosphatase alanine transaminase (ALT) and aspartate transaminase 
(AST) were investigated of the control uninfected treated with 
primaquine 250 ppm group after exerted a toxicity symptoms a long the 4 
days.  
The body weight had been taken twice a week, whereas the ration 
and dropping weights were collected from steel less trays which was take 
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three times at the whole of adaptation and examination periods to 
compare the growth performance between treated and control groups, 
and  within groups. The manure samples were examined the percent of 
bloody diarrhoea from whole dropping and oocysts count and estimated.   
The investigation of the disease causative agents was done by 
parasites identification.. The parasites were identify to levels based on 
gross lesions in postmortem findings and précised by laboratory 
examination.  
 
2.5. Laboratory investigation: 
The laboratory work was limited to calculate oosyst per gram 
(OPG) the causes of mortality only and blood parameters and liver 
functions. The entire manure output of each group that was collected at 
the first week after artificial infection. Faeces were mixed with an 
amount of water equivalent to approximately six times the volume of 
faeces and homogenized using a hand-held blender. A single 1-ml  
sample of each suspension was mix with 9 ml of 30% (wt/vol) NaNO3. 
After being mixed, samples were load into duplicate Mc Masters 
counting chambers, and the average number of oocysts was determine. 
The number of oocysts per gram of feces within each pen was estimated. 
Litter samples had been taken by collecting a handful of litter from each 
corner and the center of each tray during experiment period. The 
combined samples were mixed thoroughly and a 10 g sample was mix 
with 100 ml of tap water and allowed to stand overnight. Then the 
samples were homogenized in a mechanical blender and the homogenate 
filtered through cheesecloth. A 15-ml aliquot of the filtrate was 
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centrifuge and resuspended in 15 ml of 30% (wt/vol) NaNO3. Therefore, 
the sample was load into duplicate Mc Masters chambers and the oocysts 
were counted (Herve, 2005). 
 
2.5 1 .Faecal examination: 
For detection of coccidian oocysts individual fecal samples were 
floateted in saturated Nacl solution in test tube covered with cover slip 
for 10 minutes (simple flotation technique) then examined under 
10Xobjective of the microscope.  
 
2.5.1.1. Oocysts count: 
Positive samples were used for determination of number of oocysts 
per gram (opg) using modified McMaster technique (Anon, 1977) as 
follows: three grams of faeces were mixed with 42 ml of water using a 
pestle and mortar to make up the suspension, which was strained through 
80µ / square sieve to remove debris and the filtrate was collected in clean 
dry bowl .15ml of this filtrate were taken into centrifuge tube, 
centrifuged for 2 minutes at 110x g and the supernatant was then 
discarded. The sediment was emulsified by gentile agitation and 
saturated NaCl solution was added until the volume become equal to the 
initial aliquot of the filtrate. Then the centrifuge tube was inverted 
several times until the sediment was evenly suspended. The two 
chambers of Mc master slide were filled using clean pasture pipette. The 
slide was then left for two minutes to allow the oocysts to float and it was 
then examined under the low power (10X) of the microscope. The 
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average number of oocysts percent in the two chambers was multiplied 
by 100 to obtain the oocyst per grams (OPG).  
 
2.5.1.2. Oocysts sporulation:  
Either two or three grams of the faecal material was thoroughly 
mixed with tap water and passed through 100, 80 and 63 mesh screens. 
The filtrate was transferred into cylinder and allowed to stand overnight. 
The supernatant fluid was discarded and the sediment was divided into 
centrifuge tubes and centrifuge at 110 x for two minutes and finally the 
sediment was suspended in shallow layer of 2.5% potassium dichromate 
in Petri dishes and was left to sporulation was completed (25-27C) under 
aeration until sporulation was completed (Osman et al., 1990).  
 
2.5.1.3. Oocyst identification:  
The identification of sporulated oocyst was based on oocyst 
morphology, measurements, location and sporulation time (Goodrich, 
1944). 
 
2..5.1.3.1.. Oocyst morphology:  
Morphological characteristics of the oocysts undertaken included 
the oocysts shape (ellipsoidal, spherical or ovoidal) and the presence or 
absence of micropaylar caps (Anon, 1977). In addition to that 
photographs of oocyst previously documented by (Levine, 1973), were 
considered as aid in identification of oocyst.    
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2.5.1.3.2. Measurements of oocysts:  
Measurements of Eimeria spp. were preformed in 50-100 oocyst of 
each species. Length and width of oocysts were measured using 
calibrated an eye piece micro-meter using (Olympus, Japan) microscope 
under objective lens 40X. The measurements were done as described by 
Levine, 1973 and Anon, 1977. 
 
2.5.1.3.3. Location of infection: 
The location of the parasite within the intestine either upper, mid 
or lower portion was determined.                                                               
 
2.5.1.3.4 Sporulation time: 
Every 24 hours the faecal sample in potassium dichromate were 
examined for detections of sporulated oocyst by placing drop of faecal 
material in a microscope slide and examined under the low power (10X). 
The progress was reported until about 90% of the oocysts under the 
microscopic field were fully sporulated. 
 
2.6. Collection of blood samples: 
Blood samples for whole blood and serum were withdrawal from 
heart before and after infection using vacutainer system (Becton-
Dickinson, France). 
Wherever blood samples were taken they were divided in two 
portions; one portion was taken into plain vacutainer tubes and was 
allowed to clot prior to serum collection while the other one was taken in 
tubes containing ethylene diamine tetra acetic acid (EDTA)                                                
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2.7. Haematological methods: 
Red Blood Corpuscles (RBC), White Blood Cells (WBC), 
Differential WBC Count, Determination of Haemoglobin (HB) 
Concentration, Packed Cell Volume (PCV), Mean Corpuscular Volume 
(MCV) and Mean Corpuscular Haemoglobin Concentration (MCHC) 
were counted using the digitalized method of haematology systems or 
coagulation systems (sysmex). 
 
2.8. Liver function tests:  
Total serum   protein, albumin, phosphorus, calcium, sodium, iron 
and potassium, Alanine transaminase (ALT), Aspartate transaminase 
(AST), Alkaline phosphatase (ALP), Total bilirubin (TBIL) were 
analyzed by sysmex apparatus using the coagulation systems. 
 
2.9. Statistical analysis: 
The experimental parameters from each group were subject to 
analysis of variance using the protected least significant difference (LSD) 
method to determine the effects of treatments and the variation between 
means of the same group. A probability of P < 0.05 was considered 
significant. 
       The experiment was design accordance to block complete randomize 
design. Means, standard errored all parameters were computed.  
The statistical analysis was carried out using SPSS program 
version 13. 
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CHAPTER THREE 
RESULTS 
 
Feeding ability exerted two types of birds ability to get feed, the 
first one was recorded a significantly (p<0.05) higher ability in control 
infected not treated, treated amprolium, treated primaquine 250, 31.5 
and 125ppm, treated artesunate, treated fancedar and not infected not 
treated (2.3±1.4, 1.8±1.3, 1.7±1.3, 1.5±1.3, 1.7±1.3, 1.7±1.3, 1.7±1.3 
and 1.7±1.3), which represented medium ability score (4-0). While the 
second type secured feed forbidden appeared in not infected treated by 
amprolium, not  infected treated by primaquine 250, 31.5 and 125 
ppm, not  infected treated by artesunate and not  infected treated by 
fancedar. Moreover, the same pattern was recorded for huddle to keep 
worm score, where the control infected not treated, treated amprolium, 
treated primaquine 250, 31.5 and 125ppm, treated artesunate and 
treated fancedar showed a higher significant (p<0.05)  medium values 
(2.2±1.3, 1.8±1.3, 1.7±1.3, 1.6±1.3, 1.6±1.3, 2.3±1.3 and 1.6±1.3). 
whereas feed forbidden appeared in not infected treated by amprolium, 
not  infected treated by primaquine 250 31.5 and 125 ppm, not  
infected treated by artesunate and not  infected treated by fancedar 
recorded the lower score (0). 
3.1 Effects of Anti-malarial and Anti-coccidial drugs on infection 
symptoums: 
 
Number of survival birds during the experiment was exerted in table 
3.1, which a significantly (p<0.05) higher survived birds number were 
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secured in treated amprolium, treated primaquine 31.2ppm, treated 
artesunate, not infected not treated, not infected treated by amprolium, 
not infected treated by primaquine 31.2ppm, not infected treated by 
fancedar and not infected treated by artesunate which get 20 birds, while 
treated fancedar recorded 19.6 birds. whereas the lower numbers were 
maintained in control infected not treated, treated primaquine 250 ppm 
and not  infected treated by primaquine 250 ppm, which were get 
11.2±1.3, 9.2±1.3 and 11.6±1.3, respectively. 
The longest Survival time after treatment were recorded in all group 
except control infected not treated and not infected treated by primaquine 
250 ppm were showed (9±1.334 8.1±1.33, 9±1.12, 9±1.22, 9±0.98, 
9±1.45, 9±1.36, 9±1.23, 8.53±1.41, 9±1.52, 8.42±1.11 and 9±0.99 days) 
significantly (P<0.05) longer than that obtained in control infected not 
treated and not infected treated by primaquine 250, which were exerted 
4±1.334 and 7.22±1.34 days, respectively. 
Diseased survival birds number that bird exerted coccidiosis symptoms 
were secured a significantly (p<0.05) higher number in control infected 
not treated (8.5±1.5 birds/20 birds in ben), while not infected not treated, 
not infected treated by amprolium, not infected treated by primaquine 
250, 31.2 and 125 ppm, not infected treated by
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 artesunate and not infected treated by fancedar didn't recorded a survival 
bird. 
Feed intake conception was recorded a higher intake in not  infected 
not treated, not infected treated by amprolium, not  infected treated by 
primaquine 31.2ppm, not  infected treated by artesunate and not  infected 
treated by fancedar (1000±0.9, 1000±160, 1000±200, 978±450 and 
979±150 grams), compare with treated primaquine 250ppm, which 
secured the lowest intake (425±91 grams). 
Body weight demonstrated a significantly (p<0.05) heavier weight in 
treated primaquine 125ppm (153±20 grams), compare with control 
infected not treated, which recorded a lighter weight (78.5±20 grams). 
The data in the table 3.1 describes the impact of experimental 
medications on mortality rate during experiment. The data clearly 
indicated that mortality rate was decreased by convert of experiment to 
investigate toxicity. The percentage mortality rate in control infected not 
treated, treated primaquine 250ppm and not infected treated by 
primaquine 250 ppm were 2.0±1.1, 2.0±1.3 and 1.7±0.33%, respectively. 
While the decreased rate rose to 0.1±0.5% in Treated Fancedar and 
dropped 0% in treated amprolium, treated primaquine 31.5ppm, treated 
artesunate, not  infected not treated, not infected treated by amprolium, 
not  infected treated by primaquine 31.2ppm, not  infected treated by 
artesunate and not  infected treated by fancedar.  
 
 
58
Table (3:1): Means (+ SE) of effects of anti-malarial and acoccidial drugs on infection symptoms of the 
experimental birds 
*Means (+SE) in each coulumn followed by the same letter are not significantly different at 5% level. 
Treatments 
Feeding 
score/ 
(day) 
Huddle to 
keep 
worm 
survival 
Bird/day 
survival 
Time/(day) 
diseased 
survival/ 
(day) 
feed 
intake/gram Body weight/kg 
Mortality\ 
(day) 
Control infected. not treated 2.3a±1.4 2.2a±1.3 11.2c±1.3 4b±1.334 8.5a±1.5 845ab±91. 78.5e±20 2.0a±1.1 
Amprolium 60gm 1.8a±1.3 1.8a±1.3 20.0a±0.0 9a±1.334 1.7c±1.5 730b±81.5 86.5d±23 c0 
primaquine 250ppm 1.7a±1.3 1.7a±1.3 9.2c±1.3 8.1a±1.33 2.7b±1.5 425c±91. 94cd±35 2.0a±1.3 
primaquine 31.5ppm 1.5a±1.3 1.6a±1.3 20.0a±0.0 9a±1.12 1.3c±1.5 755b±230 87.5d±30 c0 
primaquine 125ppm 1.7a±1.3 1.6a±1.3 16.2b±1.3 9a±1.22 1.5c±1.5 755b±430 153a±20 0.7b±0.1 
Artesunate 33mg 1.7a±1.3 2.3a±1.3 20.0a±0.0 9a±0.98 2.6b±1 779b±345 120b±25 0c 
 Fancedar 86.625mg 1.7a±1.3 1.6a±1.3 19.6a±1.3 9a±1.45 4.0b±1 775b±150 101c±30.5 0.1c±0.5 
not  infected  not treated 1.7a±1.3 0b 20.0a±0.0 9a±1.36 0
d 1000a±0.9 117b±30 0
c 
not  infected treated by Amprolium 60gm 0b 0b 20.0a±0.0 9a±1.23 0
d 1000a±160 120b±15 0
c 
un  infected treated by Primaquine 250 
ppm 0
b 0b 11.6c±1.3 7.22±1.34 
0d 
655bc±210 102.5c±22 1.7a±0.33 
un  infected  treated by  Primaquine 
31.2ppm 0
b 0b 20.0a±0.0 8.53a±1.41 0
d 1000a±200 126.5b±24 0
c 
un  infected  treated by  Primaquine 125 
ppm 0
b 0b 17.2b±1.3 9a±1.52 0
d 795b±300 112.5bc±23.5 0.5b±0.32 
un  infected   treated by Artesunate 33mg 0b 0b 20.0a±0.0 8.42a±1.11 0d 978a±450 116b±25 0c 
un  infected   treated by  Fancedar 
86.625mg 0
b 0b 20.0a±0.0 9a±0.99 0
d 979a±150 108c±11 0
c 
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`3.2. Effects of anti-malarial and acoccidial drugs on infection 
symptoums of the experimental birds 
 
The data in table3.2 describing the impact of trail medications on 
disease symptoms under study. 
The significantly (p<0.05) maximum oocyst output value was exerted 
in control infected not treated (219.38±13.34), while treated amprolium 
showed (73.0±14.6 oocyst/grams). whereas the minimum value recorded 
in treated primaquine 250, 31.2 and 125 ppm, treated artesunate, treated 
fancedar, not  infected not treated, not  infected treated by amprolium, 
not  infected treated by primaquine 250, 31.2 and 125  ppm, not  infected 
treated by artesunate and not  infected treated by fancedar, which were 
did not showed an oocyst in slides. 
Bloody diarrhea score was ranged from 0 to 4. Which was 
significantly (P<0.05) higher in control infected not treated (2.50±1.64) 
compare with1.20±1.11in treated amprolium, 1.30±1.4 treated 
primaquine 250ppm, 1.40 ±1.02 in treated primaquine 31.5ppm, 1.80±1.3 
in treated primaquine 125ppm, 1.20±1.34 in treated artesunate, 1.60±1.4 
in treated fancedar and zero score in not  infected not treated, not  
infected treated by amprolium, not  infected treated by primaquine 250, 
31.2 and 125 ppm, not  infected treated by artesunate and not  infected 
treated by fancedar, respectively. 
Droping score appearance was ranged from 1 to 8, where the 
significantly (p<0.05) higher scores demonstrated in control infected not 
treated, treated amprolium, treated primaquine 250, 31.2 and 125 ppm, 
treated artesunate, treated fancedar and not  infected not treated 
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(5.7±1.334, 4.7±1.334, 3.4 ±1.334, 3.5 ±1.334, 3.2 ±1. 334, 3.5 ±1.334, 
4.7±1.334 and 4.7±1.334), compare with not  infected treated by 
amprolium, not  infected treated by primaquine 250, 31.2 and 125 ppm, 
not  infected treated by artesunate and not  infected treated by fancedar, 
which were get only one grade score. 
 Lesion scores were ranged from zero to four. control infected not 
treated exerted was significantly (p<0.05) higher score (2.7±1.4), 
compare with lower (zero) score recorded in not  infected not treated, not  
infected treated by amprolium, not  infected treated by primaquine 250, 
31.2 and 125 ppm, not  infected treated by artesunate and not  infected 
treated by fancedar, respectively. 
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Table (3:2): 
Means (+SE) of effects of anti-malarial and acoccidial drugs on 
infection symptoums of the experimental birds 
 
 
 
*Means (+SE) in each coulumn followed by the same letter are not 
significantly different at 5% level. 
Treatments Oocyst output/gram 
drop 
scores 
Bloody 
diarrhea 
Lesion 
oscores 
Control infected not treated 219.38a±13.34 5.7a±1.334 2.50a±1.64 2.70a±1.4 
treated by Amprolium 60gm 73.0b±14.6 4.7a±1.334 1.20bc±1.11 1.60b±0.99
treated by primaquine 
250ppm 0
c 3.4 a±1.334 1.30
bc±1.4 1.1bc±0.9 
treated by primaquine 
31.5ppm 0
c 3.5 a±1.334 1.40
bc±1.02 1.70b±1.4 
treated by primaquine 
125ppm 0
c 3.2 a±1.334 1.80
b±1.3 1.70b±1.21
Treated Artesunate 33mg 0c 3.5 a±1.334 1.20
bc±1.34 1.50b±1.3 
Treated Fancedar 86.625mg 0c 4.7a±1.334 1.60b±1.4 1.50b±1.3 
not inf not treated 0c 4.7a±1.334 0c 0c 
not  infected  treated by  
Amprolium 60gm 0
c 1.0b±0.0 0c 0c 
not  infected  treated by 
Primaquine 250 ppm 0
c 1.0b±0.0 0c 0c 
not  infected   treated by 
Primaquine 31.2ppm 0
c 1.0b±0.0 0c 0c 
not  infected   treated by  
Primaquine 125 ppm 0
c 1.0b±0.0 0c 0c 
not  infected   treated by 
Artesunate 33mg 0
c 1.0b±0.0 0c 0c 
not  infected   treated by 
Fancedar 86.625mg 0
c 1.0b±0.0 0c 0c 
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3.3 Effect of control un infected treated primaquine250 ppm on liver 
function tests (4 days after treatment): 
 
The data in Table (3.3) summarizes the overall means and standard 
errors of the investigated traits of liver function of the control uninfected 
treated with primaquine 250 ppm birds' group, which  was exerted a 
toxcic symptoms. The investigation was carried out for four days after 
treatment. The serum sodium, potassium, calcium, phosphate and ion 
secured a value of 129.25±23.38, 3.10±2.02, 161.6±24.95, 5.08±0.85 and 
79.0±15 respectively. whereas total billirubin., total protein, albumin, 
alkaline phosphatase, alanine transferase and aspartate transferase, which 
showed the overall values 0.25±0.2 mlg/deciliter, 1.75±0.72 g/deciliter, 
1.35±0.87 g/deciliter, 752.0±52.5 mlg/deciliter, 36.75±9.85 iu/L and 
161.0±24.95 iu/L, respectively. 
The serum sodium appeared lower value at the first experimental bird's 
group (125±20.3 µq/L) which differ significantly from the second, third 
and fourth days, which their values 134±27.8, 130±22.1 and 128.0±23.3 
µq/L, respectively (table 3:3). 
The effect of experimental treatment on serum potassium of the 
experimental bird's group secured the highest value on the second group 
(3.4 ±2 µq/L) where showed a significant difference from the first, third 
and fourth days of investigation, 4.0±1.8, 3.2 ±0.89 and 3.1±2.02 µq/L, 
respectively. 
The serum calcium of the third group appeared the highest value 
(13.0±1.38mg/decilitter), whereas the first and second days showed the 
lowest ones (10.1±1.75 and 11.6±2.0 mg/decilitter).  
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The highest value of serum phosphate appeared on the third days 
(5.5±0.7 mg/decilitter), whereas the first day secured the lowest value 
(4.8±0.9 mg/decilitter). 
The serum iron of the second group (91.0±15.3 mg/decilitter) showed 
a significant difference from the rest days, which the first day value was 
73.0±12, the third day secured 66.0±18.1 and the fourth day value was 
86.0±14.6 mg/decilitter.   
The data on table 3: 3 showing that the total billirubin of the first and 
fourth days of investigation were reviled nearly similar figures, 
0.20±0.06 g/deci-litter and 0.20±0.07 mg/decilitter, respectively. 
Whereas the second and third days secured the similar values (0.30±0.09 
and 0.30±0.06 mg/decilitter).  On the other hand the total protein values 
of the second, third and fourth days appeared nearly similar numbers, 
which they were 1.8±0.4, 1.9±0.9 and 1.9±0.8 g/decilitter, respectively. 
While the first day showed a significant different number 1.4±0.09 
mg/deciliter. On the other hands the blood albumin of the first day 
represented the lowest value (1.20±0.08 g/decilitter), whereas the fourth 
day secured the highest value (1.5±0.5 mg/decilitter).  
The alkaline phosphatase of the second day showed the highest value 
(814.0±63.5  iu/litter) which differ significantly from first, third and 
fourth days of investigation of the liver function test, which secured 
790.0±56.8, 699.0±43.7 and 705.0±44.9 iu/litter, respectively. On the 
other hand the alanine transferase of the third group maintained the 
lowest value (22.0±9.9 iu/litter) while the second and fourth days showed 
a consistent pattern of values 31.0 ±7.2 and 30.0±10.0 iu/litter, 
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respectively, whereas the alanine transferase was witnessed in the first 
day (64.0±12.3 iu/litter) and which was significantly (P<0.05) higher 
than the cross pounding values. Moreover, the aspartate transferase 
exerted nearly similar on the third and fourth days (175.0±31.0 and 
163.0±26.5 iu/litter). Which were not differ significantly (P<0.05) higher 
than the first and second days (150.0±21.3 and 156.0±21.0 iu/litter) (table 
3:3). 
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Table (3:3): 
Means (+ SE) of effect of control uninfected treated primaquine250 ppm on liver function tests (4 days after 
treatment) 
 
Means±Std. Error parameters 
 
days sodium potassium Total.Billirubin. 
Total.pro
tein Albumin 
Alkalin 
Phosphatse 
Alanine 
Transferase 
Aspartate 
Transferase Calcium Phosphate Iron 
First  125.0a±20.3 4.0a±1.8 0.20a±0.06 1.40
a±0.0
9 
1.20a±0.0
8 790.0
ab±56.8 64.0a±12.3 150.0b±21.3 10.1a±1.75 4.80ab±0.9 73.0
a 
±12.0 
Second 134.0b±27.8 3.4 b±2.0 0.30b±0.09 1.80b±0.4 1.40
b±0.0
9 814.0
b±63.5  31.0b ±7.2 156.0b±21.0 11.6ab±2.00 5.0a±1.0 91.0
b  
±15.3 
Third  130.0b 22.1 3.2ab±0.89 0.30b±0.06 1.90b ±0.9 1.30
ab±1.
0 699.0
a±43.7 22.0c±9.9 175.0a±31.0 13.0b±1.38 5.50b ±0.7 66.0
c 
±18.1 
Fourth 128.0
ab±23.
3 3.8
a±2.4 0.20a±0.07 1.90b ±0.8 1.50b±0.5 705.0a±44.9 30.0b ±10.0 163.0a±26.5 11.7ab±3.23 5.0a±0.8 86.0
ab 
±14.6 
 
*Means (+SE) in each coulumn followed by the same letter are not significantly different at 5% level. 
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3.4 Effects of anti-malarial and anti-coccidial medications on 
haematology at the first period before treatment - 4days (mcv, wbcs, 
plt, lym, & mon). 
   
 
The data pertinent to the effect exerted by trail drugs on 
investigated traits was shown in table 3.4 . The effect of anti-coccididal 
and anti-malarial drugs at first period of experiment (before treatment) on 
red blood count (RBCs) showed a consistent pattern which were differ 
insignificantly (p>0.05). The similar values were witnessed in the treated 
artesunate (2.15±0.4×103/ml) and control inf. not treated, treated 
amprolium, treated primaquine 250, 31.2 and 125ppm, not  infected 
treated by amprolium and not  infected treated by  fancedar which 
showed similar lower values (1.6×103/ml). Whereas haematocrite (HCT) 
percentages the maximum significantly (p<0.05) figures were recorded in 
treated artesunate, treated fancedar, not infected treated by primaquine 
250, 31.2 and 125 ppm and not  infected treated by  artesunate (30.2±1.5, 
29.7±1.4, 29.7±1.1, 29.7±1.34, 29.7±1.5 and 29.7±1.3%), while the 
minimum values were recorded in control inf. not treated, treated 
amprolium, treated primaquine 250, 31.2 and 125ppm, control not  
infected not treated, not  infected treated by amprolium and not  infected 
treated by  fancedar (24.6±1.4, 24.6±1.2, 24.9±1.5, 24.9±1.3, 24.9±1.1, 
24.6±1.7, 24.9±1.6 and 24.6±1.2). Mean concentration haemoglobin cells 
(mchc) of the experimental birds at the first period before treatment 
secured three different means which get a significant (P<0.05) variation, 
the first maximum value was recorded in treated primaquine 31.2ppm 
(47.3±1.6), while the medium figures secured in control infected not 
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treated, treated amprolium, treated primaquine, 250 and 125ppm, control 
not  infected not treated, not  infected treated by amprolium and not  
infected treated by  Fancedar (36.2±1.2, 36.2±1.1, 37.3±1.3, 37.3±1.4, 
36.2±1.13, 37.3±1.33 and 36.2±1.1), where the minimum values were 
reviled in treated artesunate, treated fancedar, not infected treated by 
primaquine 250, 31.2 and 125 ppm and not  infected treated by  
Artesunate (33.1±1.5, 33.7±1.5, 33.7±1.53, 33.7±1.43, 33.8±1.5 and 
33.7±1.6). Furthermore, the main plate volume (MPV) get two mean 
levels of significance the first level maintained in treated primaquine 250, 
31.2 and 125ppm, treated artesunate, treated fancedar, not  infected 
treated by amprolium, not infected treated by primaquine250, 31.2 and 
125ppm and not  infected treated by  artesunate (8.7±0.93,8.7±0.8, 
8.7±0.74, 8.7±0.67, 8.4±0.83, 8.8±0.73, 8.4±0.9, 8.4±0.93, 8.4±0.82 and 
8.4±0.57 µm3); while the second level showed a similar value (7.1 µm3) 
in control infected not treated, treated amprolium, control not  infected 
not treated and not  infected treated by  fancedar. Moreover, the plate 
diameter wall (PDW) showed the same pattern as MPV were the first 
mean level reviled in control infected not treated, treated amprolium 
treated primaquine 250, 31.2 and 125ppm, treated artesunate, control not  
infected not treated, not  infected treated by amprolium and not  infected 
treated by  fancedar (9.2±1.9, 9.2±1.3, 9.4±1.63, 9.4±1.8, 9.5±1.2, 
9.4±1.4, 9.2±1.34, 9.2±1.6 and 9.2±1.4%), while the second level 
recorded in treated fancedar, not infected treated by primaquine 250, 31.2 
and 125 ppm and not  infected treated by  artesunate, which get the 
similar percent (8.5%). 
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Table (3:4) 
Means (+SE) of effects of anti-malarial and anti-coccidial medications on haematology at the first period before 
treatment -4days. 
   
Means±Std. Error 
                                 Groups                  
Parameters 
Mean cell 
volum 
(MCV)  
White 
blood 
count 
(WBCs) 
Platlets(PLT) Lymphocyte(lym) Granulocyte(GRA) Monocyte(MON)
Control infected not treated 153.8a±5.3 117.4c±5.0 63.0b±3.5 100.8c±4.9 6.1a±1.9 10.4d±3.2 
Treated Amprolium 60gm 153.8a±5.6 117.4c±7.8 63.0b±3.2  100.8c±3.9 6.1a±1.5 10.4d±3.9 
Treated primaquine 250ppm 154.7a±3.7 121.7c±5.8 99.0a±4.6 105.3b±4.8 5.1c±0.9 11.3c±3.0 
Treated primaquine 31.5ppm 154.7a±3.5  121.7c±4.9 99.0a±5.2 105.2b±4.6 5.1c±0.85 11.3c±2.7 
Treated primaquine 125ppm 154.7a±3.9 121.7c±4.7 98.0a±4.8 105.3b±3.5  5.1c±0.73 11.3c±2.4 
Treated Artesunate 33mg 140.5b±3.2 143.3a±5.3 58.0b±5.4 112.6a±3.9 6.3a±1.1 23.4 a±3.1 
Treated Fancedar 86.625mg 140.8b±3.2  133.9b±4.9 60.0b±4.0 105.9b±4.0 5.8b±0.9 22.2b±2.8 
Control not infected not treated 153.8a±4.3 117.4c±6.8 63.0b±3.9 100.8c±3.2 6.1a±1.2 10.4±2.9 
not infected treated by 
Amprolium 60gm 154.7
a±3.8 121.7c±3.5 99.0a±4.7 105.3b±3.5 5.1c±0.9 11.3c±2.84 
not infected Treated by 
Primaquine 250 ppm 140.8
b±4.9 133.9b±3.4 60.0b±4.8 105.9b±4.0 5.8b±0.7 22.2b±3.4 
not infected treated by 
Primaquine 31.2ppm 140.8
b±3.8 133.9b±4.0 60.0b±3.1 105.9b±3.6 5.8b±0.6 22.2b±3.1 
not infected treated  by 
Primaquine 125 ppm 140.8
b±2.1 133.9b±5.0 60.0b±3.9 105.9b±3.7 5.8b±0.54 22.2b±2.4 
not infected treated by 
Artesunate 33mg 140.8
b±2.6 133.9b±5.4 99.0a±5.8 105.9b±3,8 5.9 ab±0.8 22.2b±2.1 
not infected. Fancedar 86.625mg 153.8a±5.3 117.3c±4.8 98.0a±5.1 100.8c±3.6 6.1a±0.6 10.4d±1.9 
 
*Means (+SE) in each coulumn followed by the same letter are not significantly different at 5% level. 
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3.5 Effects of anti-malarial and anti-coccidial medications on 
haematology analysis at the first period before treatment-4days 
(RBCS,HCT,MCHC,MPV,and PDW%): 
 
Table 3.5 demonstrated the effect of anti- malarial and anti-
coccidial drugs on the main cell volume, monocytes, plate count, 
lymphocytes, granulocytes and white blood count at the first 
experimental period before treatment. 
The main cell volume (MCV), recorded a significantly(p<0.05) 
higher volume in control infected not treated, treated amprolium, 
treated primaquine 250 ,31.2 and 125 ppm, control not infected not 
treated, not infected treated by amprolium and not infected treated by 
fancedar (153.8±5.3, 153.8±5.6, 154.7±3.7, 154.7±3.5 , 154.7±3.9, 
153.8±4.3, 154.7±3.8 and153.8±5.3 µm3) compare with treated 
artesunate, treated fancedar, not infected treated by primaquine 250, 
31.2 and 125 ppm and not infected treated by artesunate, which were 
showed a nearly similar values. Furthermore, white blood count 
(WBCs) maintained a maximum value recorded in treated artesunate 
(143.3±5.3×103/ml), while the minimum values recorded in control 
infected not treated, treated amprolium, treated primaquine 250, 31.2 
and 125ppm, control not infected not treated, not infected treated by 
amprolium  and not infected treated by fancedar (117.4±5.0, 
117.4±7.8, 121.7±5.8, 121.7±4.9, 121.7±4.7, 117.4±6.8, 121.7±3.5  
and 117.3±4.8×103/ml), whereas treated fancedar,  not infected treated 
by primaquine 250, 31.2 and 125 ppm and not infected treated by 
artesunate showed  a similar figure (133.9×103/ml). Moreover, plate 
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count (PLT) exerted a significantly (p<0.05) higher figure in treated 
primaquine 250, 31.2 and 125ppm, not infected treated by artesunate, 
not infected treated by amprolium and not infected treated by fancedar 
(99.0±4.6, 99.0±5.2, 98.0±4.8, 99.0±5.8, 99.0±4.7 and 98.0±5.1). 
while control infected not treated, treated amprolium, treated 
artesunate, treated fancedar, control not infected not treated, not 
infected treated by primaquine 250, 31.2 and 125 ppm were 63.0±3.5, 
63.0±3.2 , 58.0±5.4, 60.0±4.0, 63.0±3.9, 60.0±4.8, 60.0±3.1 and 
60.0±3.9, respectively (Table3:5). 
Lymphocytes (LYM) counted at the first period of experiment 
(before treatment)in treated artesunate, showed a significantly (p<0.05) 
the highest value (112.6±3.9×103/ml), where the treated primaquine 
250, 31.2 and 125ppm, treated fancedar, not infected treated by 
amprolium, not infected treated by primaquine 250, 31.2 and 125ppm 
and not infected treated by artesunate (105.3±4.8, 105.2±4.6, 
105.3±3.5 , 105.9±4.0, 105.3±3.5, 105.9±4.0, 105.9±3.6, 105.9±3.7 
and 105.9±3,8×103/ml). Whereas the lowest value maintained in 
control infected not treated, treated amprolium, control not infected not 
treated and not infected treated by fancedar, which were get a similar 
value (100.8×103/ml). On the other hand the granulocytes (GRA) 
exerted a significantly (p<0.05) higher values in control infected not 
treated, treated amprolium, treated artesunate, control not infected not 
treated and not infected treated by fancedar, which were get similar 
figure (6.1×103/ml), compare with the lower value secured in treated 
primaquine 250, 31.2 and 125ppm and not infected treated by 
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amprolium which were showed also a similar value (5.1×103/ml). The 
significantly (p<0.05) maximum value of monocytes (MON) counted 
in treated artesunate (23.4 ±3.1×103/ml). While the minimum value 
showed in control infected not treated, treated amprolium and not 
infected treated by fancedar, which were recorded same figure 
(10.4×103/ml) (table 3.5). 
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Table (3:5): Means (+SE) of effects of anti-malarial and anti-coccidial medications on haematology at the first period before treatment -4days. 
 
*Means (+SE) in each coulumn followed by the same letter are not significantly different at 5% level. 
Means±Std. Error                       Groups                     
Parameters Red Blood 
count(RBCS) 
Haematocrite
(HCT) 
Mean concentration 
haemoglobin cell(MCHC) 
Mean platelets 
volume (MPV) 
Platelets Dimeter 
wall(PDW%) 
Control infected not treated 1.6a±0.3 24.6b±1.4 36.2b±1.2 7.1b±0.8 9.2a±1.9 
Treated by Amprolium 
60gm 1.6
a±0.4 24.6b±1.2 36.2b±1.1 7.1b±0.9 9.2a±1.3 
Treated by primaquine 
250ppm 1.61
a±0.6 24.9b±1.5 37.3b±1.3 8.7a±0.93 9.4a±1.63 
Treated by primaquine 
31.5ppm 1.6
 a±0.5 24.9b±1.3 47.3a±1.6 8.7a±0.8 9.4a±1.8 
Treated by primaquine 
125ppm 1.6
a±0.65 24.9b±1.1 37.3b±1.4 8.7a±0.74 9.5a±1.2 
Treated by  Artesunate 
33mg 2.15
 a±0.4 30.2a±1.5 33.1c±1.5 8.7a±0.67 9.4a±1.4 
Treated by Fancedar 
86.625mg 2.11
a±0.5 29.7a±1.4 33.7c±1.5 8.4a±0.83 8.5b±1.6 
Control not infected not 
treated 1.73
a±0.5 24.6b±1.7 36.2b±1.13 7.1b±0.56 9.2a±1.34 
not infected  treated by  
Amprolium 1.61
a±0.32 24.9b±1.6 37.3b±1.33 8.8a±0.73 9.2a±1.6 
not infected  treated by 
Primaquine 250 ppm 2.11
a±0.7 29.7a±1.1 33.7c±1.53 8.4a±0.9 8.5b±1.3 
not infected  treated by 
Primaquine 31.2ppm 2.11
a±0.83 29.7a±1.34 33.7c±1.43 8.4a±0.93 8.5b±1.4 
not infected   treated by 
Primaquine 125 ppm 2.11
a±0.63 29.7a±1.5 33.8c±1.5 8.4a±0.82 8.5b±1.1 
not infected   treated by 
Artesunate 33mg 2.11
a±0.84 29.7a±1.3 33.7c±1.6 8.4a±0.57 8.5b±1.7 
not infected  treated by 
Fancedar 86.625mg 1.6
a±0.43 24.6b±1.2 36.2b±1.1 7.1b±0.6 9.2a±1.4 
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3.6 Effects of anti-malarial and anti-coccidial medications on 
haematology after treatment 
 
The data in the table 3.6 describes the impact of trail medications 
on the studied haematolgical parameters at second period after treatment. 
The data demonstrated that the white blood count of experimental birds 
in the second course of the trail (after treatments) showing the following 
means for the birds treated by amprolium, artesunate and not infected 
treated by primaquine 31.2ppm to test toxicity were 139.2±24.7, 
139.21±14.36×103/ml and 139.2±17.75×103/ml, which were significantly 
(p<0.05) greatest value. While control infected without treatment and not 
infected treated by primaquine 250 ppm secured similar values were 
135.71±23.6×103/ml, 135.71±16.4×103/ml, respectively. whereas the 
lowest similar values  appeared on treated primaquine 250ppm, treated 
fancedar and not infected treated by primaquine 125 ppm 
(106.5×103/ml). 
 The lymphocytes counted at second period after treatment in the 
first course of experiment (after treatments) for treated primaquine 
31.2ppm, treated primaquine 125ppm, control not infected not treated, 
not infected treated by amprolium and not infected treated by fancedar 
exerted similar figures which were significant (p<0.05) bigger than 
other counter parts which were 114.0±10.3, 113.0±13.1, 114.0±12, 
113.0±13.3 and 113.0±18.6×103/ml, respectively. Whereas the 
lymphocytes was recorded in the treated fancedar, not infected. 
primaquine 125 ppm and not infected. primaquine 125 ppm and which 
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was showed similar figures (101.1×103/ml) and were represented the 
lowest values (table 3:6). 
The plate count (PLT) at second period after treatment in the 
control not infected not treated, treated primaquine 31.2ppm and not 
infected treated artesunate were had a significantly (P<0.05) higher 
means (1063.4 ±32.2, 1044.0±67.9 and 1054.0±31.8×103/ml, 
respectively) compare with control infected not treated and not 
infected treated by primaquine 250 ppm (846.0±65.4 and 
842.0±36.8×103/ml) which represented second grade values. Whereas   
treated amprolium, treated primaquine 125ppm, treated artesunate, not 
infected treated by amprolium and not infected treated by fancedar 
(406.0±66.2, 442.0±68.8, 412.0±44.3, 441.0±42.0 
and441.0±21.7×103/ml, respectively) secured the lowest figure. 
Moreover, the mean cell volume (MCV) of treated amprolium, treated 
primaquine 125ppm, treated artesunate, control not infected not 
treated, not infected treated by primaquine 31.2ppm, not infected 
treated by artesunate, not infected treated by amprolium, treated 
primaquine 31.2ppm and  not infected treated by fancedar exerted the 
highest values (146.0±20.4,  145.1 ±20.6, 146.1±19.9,  146.8±20.2, 
146.0±13.8, 146.8±15.9, 145.1±15.4, 146.8±21.5 and 145.0±17.8 µm3) 
compared with control infected not treated and not infected treated by 
primaquine 250 ppm (140.0±19.4 and 140.0±17.6 µm3) which 
maintained the lowest value. Furthermore, the maximum value of 
mean concentration heamoglobin cells (MCHC) was recorded in 
control infected not treated and not infected treated by Primaquine 250 
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ppm, which they were had a similar figure  (42.7 g/deciliter), whereas 
the minimum value was recorded in Treated Amprolium, (33.1±4.6 
g/deciliter ). 
The data in table (3:6) showing the main plate volume (MPV) 
_at second period after treatment_ as affected by treated primaquine 
250, 31.2 and 125ppm, treated artesunate, treated fancedar, not 
infected treated by amprolium, not infected treated by primaquine 250, 
31.2 and 125 ppm and not infected treated by artesunate were 8.8±1.5, 
8.6±1.7, 8.7±1.5, 8.6±1.1, 8.6±1.4, 8.8±1.9, 8.4±1.3, 8.4±1.4, 8.4±1.2 
and 8.4±1.1 µm3, respectively. Which were demonstrated in table (3.6) 
higher volume compare with the lower ones in control infected. not 
treated, control not infected. not treated, treated amprolium and not 
infected treated by fancedar, which had the similar volume (7.1 µm3). 
Plate diameter wall (PDW) at second period after treatment 
demonstrated in control infected. not treated, treated amprolium, 
treated primaquine 250, 31.2 and 125ppm, treated artesunate, control 
not infected. not treated, not infected treated by amprolium, not 
infected treated by artesunate and not infected treated by fancedar 
secured a higher percent 9.2±2.4, 9.2±2.2, 9.6±2.5, 9.5 ±2.1, 9.6±2.2, 
9.3±2.4, 9.2±2.1, 9.2±2.7, 9.2±2.5 and 9.2±2.9%, respectively. On the 
other hand Treated Fancedar, not infected treated by Primaquine 250, 
31.2 and 125 ppm reviled the lower percentages 8.4±2.6, 8.5±2.3, 
8.5±2.3 and 8.5±2.1%, respectively (Table 3:6).  
Monocytes (MON) at second period after treatment secured a 
higher figure computed in  control infected. not treated, treated 
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amprolium, treated artesunate, not infected treated by primaquine 250 
ppm and not infected treated by primaquine 31.2ppm, which were 
21.2±6.6, 21.7±5.4, 21.7±5.7, 21.2±5.6 and 21.7±4.3×103/ml, 
respectively. While treated primaquine 31.5ppm, Treated primaquine 
125ppm, Control not infected. not treated, not infected. Amprolium not 
infected treated by Artesunate and not infected treated by Fancedar 
showed the medium values (11.2±3.2, 10.8±3.6, 11.2±2.4, 10.8±3.3, 
11.2±3.0 and 10.8±2.2×103/ml). Moreover, the other rest of 
experiment medications Treated primaquine 250ppm,  Treated 
Fancedar and not infected treated by Primaquine 125 ppm appeared 
similar lower value (4.7×103/ml) (Table 3:6). 
The maximum values of granulocytes (GRA) at second period 
after treatment were recorded in control infected not treated, treated 
amprolium, treated artesunate, not infected treated by primaquine 250 
ppm and not infected treated by primaquine 31.2ppm (5.4±1.3, 
5.2±1.8, 5.2±1.2, 5.4±1.1 and 5.2±1.4×103/ml), whereas the minimum 
similar values were recorded in treated fancedar and not infected 
treated by primaquine 125 ppm (0.07×103/ml). 
Red blood count (RBCs) at second period after treatment in 
Treated Amprolium, Treated Artesunate and not  infected treated by  
Primaquine 31.2ppm were a similar figure (1.91×103/ml), which were 
statistically differ significantly (P<0.05) from the lower values counted 
in Treated Fancedar, not  infected treated by   Primaquine 125 ppm 
and not  infected treated by   Primaquine 250 ppm (1.13±0.84, 
1.13±07. and 1.13±0.8×103/ml), while the other rest of experiment had 
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the medium values 1.77±0.34×103/ml for Control Infected. not treated, 
1.58±0.7×103/ml, for treated primaquine 31.2ppm 1.44±0.54 for 
Treated primaquine 125ppm, 1.58±0.1 for Control not infected not 
treated, 1.44±0.37for not infected Amprolium, 1.77±0.24 for not  
infected treated by  Primaquine 250 ppm, 1.58±0.6 for  not  infected 
treated by   Artesunate and 1.44±0.5 for not  infected treated by   
Fancedar (table3:6). 
 The maximum percentages of haematocrite (HCT) at second 
period after treatment exerted in only on the some treated groups, 
which were not infected treated by Primaquine 31.2ppm, Treated 
Amprolium and Treated Artesunate (27.9±5.2 27.9±7.7and 
27.9±8.7%). Whereas the minimum similar percentages secured in 
Treated primaquine 125ppm, not infected treated by Amprolium and 
not infected treated by Fancedar was 20.9% (table 3:6). 
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Table (3.6): Means (+SE) of effects of anti-malarial and anti-coccidial medications on haematology after treatment 
Means±Std. Error 
Parameters 
(WBCS) (LYM) (PLT) (MCV) (MCHC) (MPV) (PDW%) (MON) (GRA) (RBCS) (HCT) 
Control infected  not 
treated 135.71
b±23.6 109.1b±12.2 846.0b±65.4 140.0
b±19.
4 42.7
a±5.9 7.1b±1.3 9.2a±2.4 21.2
a±6.
6 
5.4a±1.
3 1.77
ab±0.34 24.8b±9.4 
Treated Amprolium 
60gm 139.2
a±24.7 112.3ab±13.4 406.0c±66.2 146.0
a±20.
4 33.1
d±4.6 7.1b±1.3 9.2a±2.2 21.7
a±5.
4 
5.2a±1.
8 1.91
a±0.25 27.9a±7.7 
Treated primaquine 
250ppm 106.5
d±14.8 101.1ab±11.2 109.0d±71.2 143.2 ab±18.7 40.5
b±6.4 8.8a±1.5 9.6a±2.5 4.7c±1.2 0.8
b±0.
25 1.13
c±0.8 16.3d±3.4 
Treated primaquine 
31.5ppm 126.91
c±13.4 114.0a±10.3 1044.0a±67.9 146.8
a 
±21.5 38.8
c±5.3 8.6a±1.7 9.5a±2.1 11.2
b±3.
2 
1.8b±0.
92 1.58
b±0.7 23.2b±2.9 
Treated primaquine 
125ppm 125.41
c±15.35 113.0a±13.1 442.0c±68.8 145.1
a 
±20.6 37.8
 d±3.4 8.7a±1.5 9.6a±2.2 10.8
b±3.
6 
1.6b±0.
94 1.44
bc±0.54 20.9c±6.8 
Treated Artesunate 
33mg 139.21
a±14.36 112.3ab±15.6 412.0c±44.3 146.1
a 
±19.9 33.1
cd±5.2 8.6a±1.1 9.3a±2.4 21.7
a±5.
7 
5.2a±1.
2 1.91
a±0.9 27.9a±8.7 
Treated Fancedar 
86.625mg 106.51
d±16.3 101.1ab ±16 116.0d±23.2  143.2 ab±17.6 40.5
b±4.7 8.6a±1.4 8.4b±2.6 4.7c±1.1 0.07
c±0
.03 1.13
c±0.84 16.3d±5.4 
Control not infected 
not treated 126.91
c±6.63 114.0a±12.8 1063.4 a±32.2 146.8
a 
±20.2 38.8
c±6.2 7.1b±1.6 9.2a±2.1 11.2
b±2.
4 
1.8b±0.
8 1.58
b±0.1 23.2b±3.4 
not infected treated by 
Amprolium 60gm 125.42
c±17.6 113.0a±13.3 441.0c±42.0 145.1
a±15.
4 37.8
cd±6.4 8.8a±1.9 9.2a±2.7 10.8
b±3.
3 
1.6b±0.
5 1.44
bc±0.37 20.9c±3.6 
not infected treated by 
Primaquine 250 ppm 135.71
b±16.4 109.1b ±10.8 842.0b±36.8 140.0
b±17.
6 42.7
a±4.8 8.4a±1.3 8.5b±2.3 21.2
a±5.
6 
5.4a±1.
1 1.77
ab±0.24 24.8b±4.7 
not infected treated by 
Primaquine 31.2ppm 139.2
a±17.75 112.3ab ±9.3 402.0c±23.6 146.0
a±13.
8 33.1
cd±6.5 8.4a±1,4 8.5b±2.3 21.7
a±4.
3 
5.2a±1.
4 1.91
a±0.3 27.9a±5.2 
not infected treated by 
Primaquine 125 ppm 106.51
d±18.64 101.1ab ±8.5 106.0d±27.9 143.2 ab±19.3 40.5
b±4.9 8.4a±1.2 8.5b±2.1 4.7c±1.0 0.7
c±0.
24 1.13
c±0.7 16.3d±3.2 
not infected treated by 
Artesunate 33mg 126.9
c±16.9 112.0ab ±9.9 1054.0a±31.8 146.8
a±15.
9 38.8
c±5.5 8.4a±1.1 9.2a±2.5 11.2
b±3.
0 
1.9b±0.
4 1.58
b±0.6 23.2b±7.3 
not infected treated by 
Fancedar 86.625mg 125.42
c±18.87 113.0a±18.6 441.0c±21.7 145.0
a±17.
8 37.8
cd±3.5  7.1b±1.2 9.2a±2.9 10.8
b±2.
2 
1.6b±0.
44 1.44
bc±0.5 20.9c±8.5 
*Means (+SE) in each coulumn followed by the same letter are not significantly different at 5% level. 
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CHAPTER FOUR 
DISCUSSION 
 
The effects of aretsunate used in this experiment on whole 
performance and reduction of coccidiosis symptoms may be attributed to 
the compound with anti-malarial activity that justified by Allen et al. 
(1996) due to its potential to elicit oxidative stress which is effective in 
controlling caecal coccidian and exhibit the disease activity. One of the 
suppositions of this experiment was primaquine the anti-malarial 
component of this drug appeared a strong tendency to exhibit anti-
coccidial activity. 
The protective effects of the medications used in this experiments 
was suggested by both body weight and lesion scores data (table 4:) 
although un challenge chicks treated by primaquine 250 ppm exerted a 
toxicity behavior appeared on the sudden death and liver function tests 
which was secured in table (4:). Moreover, the effects and toxicity of 
primaquine at level 250 ppm in control un inoculated group was in  
agreement with Matsuno et al. (1991) results which they were report 
primaquine controlled the clinical signs of coccidiosis at level above 31.2 
ppm and showed a tendency apparently to reduce body weight at 500 
ppm. This toxicity will also be related to Schmidt's theory (Schmidt, 
1951) on the extent of substitution of terminal amion-nitrogen, that 
primaquine with a primary amino terminus.    
Whether the differences in anti-coccidial and anti-malarial and 
their levels observed on the experimental groups perhaps due to the 
reflection of differences in mode of actions against the parasite and may 
80 
 
be to the differences in their metabolism in chickens. Although the mode 
of action of the 8-amino-quinolines against blood parasites was not 
clearly proved, but the most supported one is base on the inhibition of 
metabolic pathway and protein-synthesis of the protozoa. 
In the ensuing years, coccidial lesion scores and weight gain in 
particular the procedure described by Johnson and Reid (1970) assumed 
an important role as a measure of anti-coccidial efficacy. Moreover, the 
medication effects are attributed perhaps due to the efficacy of anti-
malarial and anti-coccidial drugs and precision. 
 Caecal lesion scores  obtained in this experiment of medicated 
groups secured lower lesion scores compare with control infected groups 
this result was in agreement with the results recorded by Patrica, et al. 
(1997) in their study on Artemisia annua as supplementary levels on diet, 
and the authors suggested that A. annua might afford some protection 
against E. tenella. On the other hand this result was disagreeing with the 
result obtained by Conway et al. (1999). 
 A number of workers have shown that significant differences in 
comparable lesion scores depending on whether they were immunized or 
un immunized or medicated or un medicated (Long et al., 1980, 
Augustine et al., 1999, 1993). Hee and Jae (2001) mentioned that lesion 
scores in the groups treated with umacrocarpa (1.4) or pulsatilla koreena 
(1.6) which were significantly lower than those of infected control group 
were their lesion scores was 3. It is possible that tissue damage and 
changes in the functional integrity of the intestine may allow colonization 
of the gut by various types of harmful bacteria, leading to 
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infectedlammation of the intestine, followed by cellular infectediltration 
(Rose et al., 1979)   
Development of typical caecal lesions appeared in infected treated 
groups was prevented when treatment with artesunate, primaquine, 
fancedar and amprolium is may be initiated before large of second 
generation of shizonts appear. Moreover, may be due to the lethal ability 
against both sexual and asexual stages of E. tenella and properly due to 
interrupted at a very early stage of oocyst shelling are prevented. Reid 
(1975) classified that amprolium as a rapid anti-coccidial drug in 
recovery coccidiosis.  
The lowest oocyst out put obtained from treatment groups may be 
due to the effect of treatment especially the anti-malarial medications that 
the mode of action of artesunate has been attributed to its potential to 
induce a state of oxidative stress though the free radical cascade 
generator by the endoperoxide function (Krung Kraiand Yuthavong, 
1987; Levander et al., 1989). and the ability of the free radical alkylate 
protein (Yang et al., 1994) and the induced oxidative stress can be 
effective in reducing caecal lesion. Moreover, amprolium competitively 
inhibits thiamine utilization by the parasite. Prolonged high dosages can 
cause thiamine deficiency in the host and excessive thiamine in the diet 
can reduce or reverse the anticoccidial activity of the drug. Amprolium 
reportedly acts primarily upon the first generation schizont in the cells of 
the intestinal wall, preventing differentiation of the metrozoites. It may 
also suppress the sexual stages and sporulation of the oocysts. 
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Body weight performance in this study was exerted the lowest 
weight in control infected not treated group compare with infected 
medicated groups which the highest body weight with in this group 
recorded in infected treated by primaquine 125 ppm, although the 
medium weight was recorded in control un infected treated groups, this 
pattern is similar to that mentioned by Walden Stedt et al. (1999) and 
Hee and Jae (2001). This result may be due to the mechanism of the 
medications on control un infected treated groups as prophylactic  
additives and suppression of  infectedection activity, moreover, the result 
of increasing of body weight in infected treated by primaquine 125 ppm 
in agreement to the results obtained by Matsuno et al. (1991) which 
showed a tendency apparently to increase body weight compare with 
control not infected treated by primaquine groups which exerted an 
observable tendency to reduce body weight, and they were pointed the 
tendency at 500 ppm. On the other hand the extent of weigt gain for all 
medicated with amprolium groups were susceptaible to amprolium. 
Therefore, Ogbe et al. (2008) found that the infected medicated groups 
exerted a higher body weight compare with infected unmedicated. 
The faecal scores were significantly lower (P<0.05) in the infected 
medicated groups compare with infected un medicated groups through 
out the experiment 
Death may follow the acute disease either directly or from 
secondary diseases such as pneumonia. Birds that survive for 5 to 7 days 
may recover control infected un medicated group, however, permanent 
damage may occur as lesion scores, oocyst output, bloody diarrhea. Zakia 
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et al. (1990) mentioned that an outbreak of coccidiosis was reported 
among 8-week-old white hisex chickens in Khartoum province with 
55.5% and 19.5% morbidity and mortality rates, respectively, which they 
were identified E. tenella 52.5%. Moreover, Chapman (1989) recorded 
that treatment with amprolium prevent mortality in chicken infected with 
field isolates of E. tenella. From above suggested that amprolium was 
used to control reactions and avoid mortality without interrupting 
immunity development. The use of this drug, however, in high doses 
and/or for long time periods can interfere with the development of 
immunity (cycle uniformity) in birds that were correctly vaccinated. On 
the other hand while amprolium can interfere with immunity 
development of all Eimeria species, particular care should be taken to 
avoid interfering with Eimeria tenella cycling. The low number of 
oocysts out put as a consequence, immunity development takes longer. 
Moreover, the excessive use of amprolium can interfere with the 
development of immunity against this specie.  
Research has indicated that birds may experience reduced food 
consumption in control un infected un medicated group following clinical 
infectedection compare with the infected treated groups. Which may be 
due to the challenges of infectedection and in medicated groups may be 
due to the utilization of these drugs as treatment and control drugs 
(Apyne, 1977).  
Diarrhea may be present in the animal before the oocysts can be 
found; therefore, a confirmed laboratory diagnosis may not always be 
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possible. Laboratory findings should be correlated with clinical signs for 
a diagnosis. 
Haematological parameters, particularly haematocrit, are 
frequently used in assessing condition in birds. Mean corpuscular volume 
(MCV) overcomes some of the drawbacks associated with measuring 
haematocrits and therefore should be a better condition index. In this 
study investigated the relationships between these blood parameters and 
the breeding performances of challenged and un challenged birds with E. 
tenella. Moreover, The infectedection with E. tenella resulted in 
reduction in red blood cell (RBC) counts and haemoglobin content, 
increase in the mean corpuscular haemoglobin (MCH), the mean 
corpuscular haemoglobin concentration (MCHC), the mean corpuscular 
volume (MCV) and the haemoglobin index (HbI), indicating the 
development of a hyperchromic anaemia. The white blood cell (WBC) 
counts were elevated as well as the percentages of eosinophils and 
monocytes following activation of the innate defense mechanisms. 
Lymphocyte percentages were lower. Both qualitative and quantitative 
haematological changes observed in chickens, infected with E. tenella, 
were the highest during the period of most intensive invasion.  
85 
 
CONCLUSION AND RECOMMENDATIONS 
 
The present knowledge on the pharmacology and impact of 
parasitic diseases on productivity performance and health. There is a 
need to conduct a range of studies in this area in order to fill the gaps in 
the knowledge base. To date Eimeria spp. and plasmodium spp. are 
secured similar metabolic function in several recent studies, which build 
this research hypothesis to utilize the anti-malarial drugs to suppress the 
infectedection of Eimeria spp. As indicated in Chapters 4 the anti-
malarial  medications-primaquine, fancedar and artesunate- revealed 
apparently tendency to prophylactic tendency and recovery the 
infectedection of Eimeria tenella, in spite of the un infected treated by 
primaquine secured toxic symptoms at level 250 ppm, causing not only 
heavy production losses، but also death. 
This sutudy recommended that the utilization of anti-malarial 
medications primaquine, artesunate and fancedar are useful to 
adiminstrate the Eimeria tenella infectedection especially primaquine 
inmodrate level 125 ppm which take a short time (5 days) and least cost 
compare with antimalarial drugs. The other utility of these drugs as 
control drug and prophylactic additive, which exearted higher 
performance compare with anti-coccidial drugs represented in 
amprolium. Moreover, when medicated the coccidiosis with anti-malarial 
drugs must take care to avoid highly levels and over doses, to avoid the 
reduction on total performance in chickens and sudden death as symptom 
of toxicicty. 
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APPENDIXES AND FIGURES 
APPENDIX ONE: 
Analysis of Variance for the experimental medications 
Source of Variation df Mean Square F Sig.
not infected not treated 2 Between 
control infected not treated 2 4157.267** 2.26 .01 
not infected not treated 2 Control  Within 
control infected not treated 2 29192.494
NS .406  .844
Anti-coccidial drugs 2 
Anti-malarial drugs 35Between treatments Treated not infected 8 
6983.82** 5.024 .007
Primaquine  8 6755.9** 3.2 31 .009
Fancedar 8 8953.21* 3.900 .022
Artisunate 8 10365.907* 2.56 .041
Treatment 
within 
treatments
Amprolium 8 82053.402NS 0.58 .932
Treated not infected 18 28906.785   
not infected not treated 18 76919.530   
infected not treated 18 13194.056   
Primaquine 18 79425.159   
Fancedar 18 27246.304   
Artisunate 18 7809.210   
Error  
Amprolium 18 65840.342   
* Significant at 1% level. 
*  Significant at 5% level. 
NS  not significant.
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FIGURE ONE:  
Oocysts of Eimeria tenella 
113 
 
FIGURE TWO:  
Sporulated  oocysts of Eimeria tenella 
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FIGURE Three: 
Infected caecum by Eimeria tenella 
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FIGURE Four: 
Eimeria  tenella  life cycle 
 
 
 
 
 
 
 
